Source: http://www.google.com/patents/US6150130?dq=6,373,753
Timestamp: 2014-08-29 16:46:57
Document Index: 267556943

Matched Legal Cases: ['Application No. 58786', 'Application No. 53255', 'Application No. 58786', 'Application No. 53255', 'Application No. 58786', 'Application No. 53255', 'Application No. 58786', 'Application No. 53255', 'Application No. 70335']

Patent US6150130 - Introducing dna strand into microorganism capable of synthesizing a beta ... - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Sign in<nobr>Advanced Patent Search</nobr>PatentsDisclosed are the following DNA strands relating to the synthesis of keto group-containing xanthophylls such as astaxanthin and the like, and the techniques relating to the production of xanthophylls by genetic engineering: A DNA strand having a nucleotide sequence which encodes a polypeptide having...http://www.google.com/patents/US6150130?utm_source=gb-gplus-sharePatent US6150130 - Introducing dna strand into microorganism capable of synthesizing a beta-carotene, wherein the dna strand encodes a polypeptide capable of converting the methylene group at the 4-position of a beta-ionone ring into a keto group, culturingAdvanced Patent SearchPublication numberUS6150130 APublication typeGrantApplication numberUS 09/335,919Publication dateNov 21, 2000Filing dateJun 18, 1999Priority dateDec 27, 1993Fee statusPaidAlso published asCA2180024A1, CA2180024C, DE69433969D1, DE69433969T2, EP0735137A1, EP0735137A4, EP0735137B1, EP1203818A2, EP1203818A3, US5811273, US5972690, WO1995018220A1Publication number09335919, 335919, US 6150130 A, US 6150130A, US-A-6150130, US6150130 A, US6150130AInventorsNorihiko Misawa, Keiji Kondo, Susumu Kajiwara, Akihiro YokoyamaOriginal AssigneeKirin Beer Kabushiki Kaisha, Marine Biotechnology Institute Co., Ltd.Export CitationBiBTeX, EndNote, RefManPatent Citations (2), Non-Patent Citations (8), Referenced by (12), Classifications (17), Legal Events (5) External Links: USPTO, USPTO Assignment, EspacenetIntroducing dna strand into microorganism capable of synthesizing a beta-carotene, wherein the dna strand encodes a polypeptide capable of converting the methylene group at the 4-position of a beta-ionone ring into a keto group, culturingUS 6150130 AAbstract Disclosed are the following DNA strands relating to the synthesis of keto group-containing xanthophylls such as astaxanthin and the like, and the techniques relating to the production of xanthophylls by genetic engineering:
A DNA strand having a nucleotide sequence which encodes a polypeptide having an enzyme activity for converting a methylene group at the 4-position of a β-ionone ring into a keto group.
What is claimed is: 1. A method for producing a xanthophyll comprising:(a) introducing a DNA strand into a microorganism capable of synthesizing a β-carotene, wherein the DNA strand encodes a polypeptide capable of converting the methylene group at the 4-position of a β-ionone ring into a keto group, (b) culturing the microorganism obtained in (a) in a culture medium, and (c) obtaining canthaxanthin or echinenone from the microorganism cultured in (b). 2. The method of claim 1, wherein the polypeptide is found in Agrobacterium or Alcaligenes.
3. The method of claim 1, wherein the DNA strand hybrdizes to the complement of another DNA strand comprising the nucleotide sequence of SEQ ID NO: 1 or SEQ ID NO: 8 in a solution comprising 5�SSC and 6�Denhardt for 16 hours at 60� C. follwed by washing in a solution comprising 2�SSC and 0.1% SDS for 1 hour at 60� C.
4. The method of claim 1, wherein the polypeptide comprises the amino acid sequence encoded by the nucleotide sequence of SEQ ID NO: 1 or SEQ ID NO: 8.
5. The method of claim 1, wherein the β-ionone ring is a 3-hydroxy-β-ionone ring.
6. The method of claim 1, wherein the microorganism is a bacterium or a yeast.
7. A method for producing a xanthophyll comprising:(a) introducing a DNA strand into a microorganism capable of synthesizing a zeaxanthin, wherein the DNA strand encodes a polypeptide capable of converting the methylene group at the 4-position of a β-ionone ring into a keto group, (b) culturing the microorganism obtained in (a) in a culture medium, and (c) obtaining astaxanthin or 4-ketozeaxanthin from the microorganism cultured in (b). 8. The method of claim 7, wherein the polypeptide is found in Agrobacterium or Alcaligenes.
9. The method of claim 7, wherein the DNA strand hybrdizes to the complement of another DNA strand comprising the nucleotide sequence of SEQ ID NO: 1 or SEQ ID NO: 8 in a solution comprising 5�SSC and 6�Denhardt for 16 hours at 60� C. follwed by washing in a solution comprising 2�SSC and 0.1% SDS for 1 hour at 60� C.
10. The method of claim 7, wherein the polypeptide comprises the amino acid sequence encoded by the nucleotide sequence of SEQ ID NO: 1 or SEQ ID NO: 8.
11. The method of claim 7, wherein the β-ionone ring is a 3-hydroxy-β-ionone ring.
12. The method of claim 7, wherein the microorganism is a bacterium or a yeast.
This application is a divisional of application Ser. No. 09/006,491, filed Jan. 13, 1998, now U.S. Pat. No. 5,972,690 which is in turn a divisional of application Ser. No. 08/663,310, filed Sep. 23, 1996, now U.S. Pat. No. 5,811,273 which is in turn national stage of PCT/JP94/02220, filed Dec. 26, 1994.
The present inventors have recently made it possible to clone a carotenoid biosynthesis gene cluster from a epiphytic non-photosynthetic bacterium Erwinia uredovora in Escherichia coli with an index of the yellow tone of the bacterium, a variety of combinations of the genes being expressed in microorganisms such as Escherichia coli to produce phytoene, lycopene, β-carotene, and zeaxanthin which is a derivative of β-carotene into which hydroxyl groups have been introduced (See FIG. 10; Misawa, N., Nakagawa, M., Kobayashi, K., Yamano, S., Izawa, Y., Nakamura, K., Harashima, K.; "Elucidation of the Erwinia uredovora Carotenoid biosynthetic Pathway by Functional Analysis of Gene Products Expressed in Escherichia coli", J. Bacteriol., 172, p.6704-6712, 1990; Misawa, N., Yamano, S., Ikenaga, H., "Production of β-carotene in Zymomonas mobilis and Agrobacterium tumefaciencs by Introduction of the Biosynthesis Genes from Erwinia uredovora", Appl. environ. Microbiol., 57, p. 1847-1849, 1991; and Japanese Patent Application No. 58786/1991 (Japanese Patent Application No. 53255/1990): "DNA Strands useful for the Synthesis of Carotenoids").
On the other hand, astaxanthin, a red xanthophyll, is a typical animal carotenoid which occurs particularly in a wide variety of marine animals including red fishes such as a sea bream and a salmon, and crustaceans such as a crab and a lobster. In general, animals cannot biosynthesize carotenoids, so that it is necessary for them to ingest carotenoids synthesized by microorganisms or plants from their environments. Thus, astaxanthin hitherto has been used widely for strengthening the color of cultured fishes and shellfishes such as sea bream, salmon, lobster and the like. Moreover, astaxanthin has attracted attention not only as a coloring matter in foods but also as an anti-oxidant for removing active oxygen generated in bodies, which causes carcinoma (see Takao Matsuno ed., "Physiological Functions and Bioactivities of Carotenoids in Animals", Kagaku to Seibutsu, 28, p. 219-227, 1990). As the sources of astaxanthin, there have been known crustaceans such as a krill in the Antarctic Ocean, cultured products of a yeast Phaffia, cultured products of a green alga Haematococcus, and products obtained by the organic synthetic methods. However, when crustaceans such as krill in the Antarctic Ocean or the like are used, requires laborious work and much expense is required for the isolation of astaxantin from contaminants such as lipids and like during harvesting and extraction of krill. Moreover, in the case of the cultured products from the yeast Phaffia, a great deal of expense is incurred for the gathering and extraction of astaxanthin, because yeast has rigid cell walls and produces astaxanthin in a low yield. Also, in the case of the cultured product of the green alga Haematococcus, not only a location for collecting sunlight or an investment of a culturing apparatus for supplying an artificial light is required in order to supply light which is essential to the synthesis of astaxantin, but also it is difficult to separate astaxanthin from fatty acid esters as by-products or chlorophylls present in the cultured products. For these reasons, astaxanthin produced from biological sources presently is inferior to that obtained by organic synthetic methods due to cost. Organic synthetic methods however, produce by-products. Thus, in context of its use as a feed for fishes and shellfishes and an additive to foods, the products obtained by these organic synthetic methods are unacceptable due to the consumer's preference for natural products. Accordingly, it is desired to supply an inexpensive astaxanthin that is safe and produced from biological sources and thus present a good image to consumers, and to develop a process for producing astaxanthin.
DISCLOSURE OF THE INVENTION It would be considred very useful to find the genes that play a role in the biosynthesis of astaxanthin, because this advance would allow astaxanthin-production from microorganisms to optimize in safety for production a food and also allow astaxanthin, regardless of the presence of astaxanthin-producing ability of a microorganism, by introducing a gene cluster for astaxanthin biosynthesis into the microorganism. No problem of by-products as contaminants is incurred in this case; thus it would be consiered not difficult to increase the production amount of astaxanthin with a recent advanced technique of gene manipulation to a level higher than that accomplished by the organic synthetic methods. However, the groups of genes for synthesizing zeaxanthin, one of the xanthophylls, have already been acquired by the present inventors as described above, while no genes encoding a keto group-introducing enzyme required for the synthesis of astaxanthin have not successfully obtained. The reason for failure in obtaining the genes includes that the keto group-introducing enzyme is a membrane protein and loses its activity when isolated from the membrane, so that it was impossible to purify the enzyme or measure its activity and no information on the enzyme has been obtained. Thus, it has hitherto been impossible to produce astaxanthin in microorganisms by gene manipulation.
The gene cloning method which is often used usually comprising purifying the desired protein, partially determining the amino acid sequence and obtaining genes by a synthetic probe. This however, cannot be used because of the purification of the astaxanthin synthetic enzyme is impossible, as described above. Thus, the present inventors have paid attention to the fact that the cluster of carotenoid synthesis genes in non-photosynthetic bacterium (Erwinia) functions in Escherichia coli, in which lycopene and β-carotene which are believed to be intermediates for biosynthesis of astaxanthin, are allowed to produce with combinations of the genes from the gene cluster, and have used Escherichia coli as a host for cloning of astaxanthin synthetic genes. The present inventors also have paid attention to the fact that some marine bacteria have an astaxanthin-producing ability (Yokoyama, A., Izumida, H., Miki, W., "Marine bacteria produced astaxanthin", 10th International Symposium on Carotenoids, Abstract, CL11-3, 1993), that a series of related genes would constitute a cluster in the case of bacteria, and that the gene cluster would be expressed functionally in Escherichia coli in the case of bacteria. The present inventors have thus selected marine bacteria as gene sources. They have carried out research with a combination of these two means and successfully obtained the gene group which is required for the biosynthesis of astaxanthin and the other keto group-containing xanthophylls from marine bacteria. They have thus accomplished the present invention. In addition, it has been first elucidated in the present invention that the astaxanthin synthesis gene cluster in marine bacteria constitutes a cluster and expresses its function in Escherichia coli, and these gene products can utilize β-carotene or lycopene as a substrate.
(2) A DNA strand having a nucleotide sequence which encodes a polypeptide having an enzyme activity for converting the methylene group at the 4-position of the β-ionone ring into a keto group and having an amino acid sequence substantially of amino acid Nos. 1-212 which is shown in the SEQ ID NO: 2.
(4) A DNA strand having a nucleotide sequence which encodes a polypeptide having an enzyme activity for converting the methylene group at the 4-position of the β-ionone ring into a keto group and having an amino acid sequence substantially of amino acid Nos. 1-242 which is shown in the SEQ ID NO: 9.
(6) A DNA strand having a nucleotide sequence which encodes a polypeptide having an enzyme activity for converting β-carotene into canthaxanthin via echinenone and having an amino acid sequence substantially of amino acid Nos. 1-212 which is shown in the SEQ ID NO: 2.
(8) A DNA strand having a nucleotide sequence which encodes a polypeptide having an enzyme activity for converting β-carotene into canthaxanthin via echinenone and having an amino acid sequence substantially of amino acid Nos. 1-242 which is shown in the SEQ ID NO: 9.
(11) A DNA strand having a nucleotide sequence which encodes a polypeptide having an enzyme activity for converting the methylene group at the 4-position of the 3-hydroxy-β-ionone ring into a keto group and having an amino acid sequence substantially of amino acid Nos. 1-212 which is shown in the SEQ ID NO: 2.
(13) A DNA strand having a nucleotide sequence which. encodes a polypeptide having an enzyme activity for converting the methylene group at the 4-position of the 3-hydroxy-β-ionone ring into a keto group and having an amino acid sequence substantially of amino acid Nos. 1-242 which is shown in the SEQ ID NO: 9.
(15) A DNA strand having a nucleotide sequence which encodes a polypeptide having an enzyme activity for converting zeaxanthin into astaxanthin by way of 4-ketozeaxanthin and having an amino acid sequence substantially of amino acid Nos. 1-212 which is shown in the SEQ ID NO: 2.
(17) A DNA strand having a nucleotide sequence which encodes a polypeptide having an enzyme activity for converting zeaxanthin into astaxanthin by way of 4-ketozeaxanthin and having an amino acid sequence substantially of amino acid Nos. 1-242 which is shown in the SEQ ID NO: 9.
(20) A DNA strand having a nucleotide sequence which encodes a polypeptide having an enzyme activity for adding a hydroxyl group to position 3-carbon of the 4-keto-β-ionone ring and having an amino acid sequence substantially of amino acid Nos. 1-162 which is shown in the SEQ ID NO: 4.
(22) A DNA strand having a nucleotide sequence which encodes a polypeptide having an enzyme activity for adding a hydroxyl group to position 3-carbon of the 4-keto-β-ionone ring and having an amino acid sequence substantially of amino acid Nos. 1-162 which is shown in the SEQ ID NO: 11.
(24) A DNA strand having a nucleotide sequence which encodes a polypeptide having an enzyme activity for converting canthaxanthin into astaxanthin by way of phoenicoxanthin and having an amino acid sequence substantially of amino acid Nos. 1-162 which is shown in the SEQ ID NO: 4.
(26) A DNA strand having a nucleotide sequence which encodes a polypeptide having an enzyme activity for converting canthaxanthin into astaxanthin by way of phoenicoxanthin and having an amino acid sequence substantially of amino acid Nos. 1-162 which is shown in the SEQ ID NO: 11.
BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 the nucleotide sequence encoding the keto group-introducing enzyme (crt W gene) of the marine bacterium Agrobacterium aurantiacus sp. nov. MK1 and the corresponding amino acid sequence (SEQ ID NOS: 1-2).
FIG. 2 the nucleotide sequence of the hydroxyl group-introducing enzyme gene (crt Z gene) of the marine bacterium Agrobacterium aurantiacus sp. nov. MK1 and the corresponding amino acid sequence (SEQ ID NOS: 3-4).
FIG. 3 the nucleotide sequence encoding the lycopene-cyclizing enzyme gene (crt Y gene) of the marine bacterium Agrobacterium aurantiacus sp. nov. MK1 and the corresponding amino acid sequence (SEQ ID NOS: 5-6).
FIG. 4 continuation of the sequences in FIG. 3.
FIG. 5 the nucleotide sequence of the xanthophyll synthesis gene cluster of the marine bacterium Agrobacterium aurantiacus sp. nov. MK1 (SEQ ID NO: 7).
FIG. 6 continuation of the sequence in FIG. 5.
FIG. 7 continuation of the sequence in FIG. 6.
FIG. 8 continuation of the sequence in FIG. 7.
FIG. 9 continuation of the sequence in FIG. 8.
FIG. 10 carotenoids biosynthetic route of the non-photosynthesis bacterium Erwinia uredovora and the functions of the carotenoid synthetic genes.
FIG. 11 the main xanthophyll biosynthetic routes of marine bacteria Agrobacterium aurantiacus sp. nov. MK1 and Alcaligenes sp. PC-1 and the functions of the xanthophyll synthesis genes.
FIG. 12 variety of deletion plasmids containing the xanthophyll synthesis genes (cluster) of the marine bacterium Agrobacterium aurantiacus sp. nov. MK1.
The letter represents the promoter of the lac of the vector pBluescript II SK. The positions of cutting with restriction enzymes are represented by abbreviations as follows: Sa, SacI; X, XbaI; B, BamHI; P, PstI; E, EcoRI; S, SalI; A, ApaI; K, KpnI; St, StuI; N, NruI; Bg, BglII; Nc, NcoI; Hc, HincII.
FIG. 13 the nucleotide sequence encoding the keto group-introducing enzyme gene (crtW gene) of the marine bacterium Alcaligenes sp. PC-1 and the corresponding amino acid sequence (SEQ ID NOS: 8-9).
FIG. 14 the continuation of the sequences in FIG. 13.
FIG. 15 the nucleotide sequence encoding the hydroxyl group-introducing enzyme gene (crtZ gene) of the marine bacterium Alcaligenes sp. PC-1 and the corresponding amino acid sequence (SEQ ID NOS: 10-11).
FIG. 16 the nucleotide sequence of the xanthophyll synthetic gene cluster of the marine bacterium Alcaligenes sp. PC-1 (SEQ ID NOS: 12). The letters A-D in FIG. 16 correspond to those in FIGS. 13-15.
FIG. 17 continuation of the sequence in FIG. 16 (SEQ ID NO: 12).
FIG. 18 continuation of the sequences in FIG. 17 (SEQ ID NO: 12).
FIG. 19 deletion plasmids containing the xanthophyll synthetic genes (cluster) of the marine bacterium Alcaligenes sp. PC-1.
The letter represents the promoter of the lac of the vector pBluescript II SK+.
The polypeptides encoded by the DNA strands according to the present invention have amino acid sequences substantially in a specific range as described above in SEQ ID NOS: 2, 4, 9, and 11 (FIGS. 1-2, and 13-15), e.g. an amino acid sequence of amino acid Nos. 1-212 in SEQ ID NO: 2 (A-B in FIG. 1). In the present invention, four polypeptides encoded by these DNA strands, that is four enzymes participating in the xanthophyll-producing reaction) may be modified by deletion, substitution or addition in some of the amino acids provided that the polypeptides have the enzyme activities as described above (see Example 13). This corresponds to that "amino acid sequences . . . substantially . . . " For instance, an enzyme of which amino acid at the first position (Met) has been deleted is also involved in the polypeptide or enzyme obtained by the modification of the amino acid sequence. In this connection, it is needless to say that the DNA strands according to the present invention for encoding the polypeptides also include, in addition to those having nucleotide sequences in a specific range shown in SEQ ID NOS: 2, 4, 9, and 11 (FIGS. 1-2, and 13-15), degenerate isomers encoding the same polypeptides as above except degenerate codons.
Keto Group-introducing Enzyme Gene (crtW) The DNA strands (1)-(18) are genes which encode the keto group-introducing enzymes (referred to hereinafter as crtW). Typical examples of the genes are crtW genes cloned from the marine bacteria Agrobacterium aurantiacus sp. nov. MK1 or Alcaligenes sp. PC-1, which are the DNA strands comprising the nucleotide sequences encoding the polypeptides having the amino acid sequences A-B in FIG. 1 (amino acid Nos. 2-212 in SEQ ID NO: 1) or A-B in FIGS. 13-14 (amino acid Nos. 1-242 in SEQ ID NO: 9). The crtW gene product (also referred to hereinafter as CrtW) has an enzyme activity for converting the 4-methylene group of the β-ionone ring into a keto group, and one of the specific examples is an enzyme activity for synthesizing canthaxanthin with β-carotene as a substrate by way of echinenone (see FIG. 11). In addition, the crtW gene product also has an enzyme activity for converting the 4-methylene group of the 3-hydroxy-β-ionone ring into a keto group, and one of the specific examples is an enzyme activity for synthesizing astaxanthin with zeaxanthin as a substrate by way of 4-ketozeaxanthin (see FIG. 11). In this connection, the polypeptides having such enzyme activities and the DNA strands encoding the polypeptides have not hitherto been reported, and the polypeptides or the DNA strands encoding the polypeptides has no overall homology to polypeptides or DNA strands which have hitherto been reported. Moreover, no such information has been reported that one enzyme has an activity to convert directly a methylene group of not only the β-ionone ring and the 3-hydroxy-β-ionone ring but also the other compounds into a keto group. Moreover, a homology of CrtW as high as 83% identity at an amino acid sequence level was shown between Agrobacterium and Alcaligenes.
On the other hand, it is possible to allow a microorganism such as Escherichia coli or the like to produce β-carotene or zeaxanthin by using the carotenoid synthesis genes of the non-photosynthetic bacterium Erwinia, that is the crtE, crtB, crtI and crtY genes of Erwinia afford the microorganism such as Escherichia coli or the like the β-carotene-producing ability, and the crtE, crtB, crtI, crtY and crtZ genes of Erwinia afford the microorganisms such as Escherichia coli or the like the zeaxanthin-producing ability (see FIG. 10 and Laid-Open Publication of WO91/13078). Thus, the substrate of CrtW is supplied by the crt gene cluster of Erwinia, so that when an additional crtW gene is introduced into a the microorganism such as Escherichia coli or the like which contains the aforementioned crt gene cluster of Erwinia, the β-carotene-producing microorganism will produce canthaxanthin by way of echinenone, and the zeaxanthin-producing microorganism will produce astaxanthin by way of 4-ketozeaxanthin.
Hydroxyl Group-introducing Enzyme Gene (crtZ) The DNA strands (19)-(27) are genes encoding a hydroxyl group-introducing enzyme (referred to hereinafter as crtZ). Typical examples of the genes are crtZ genes cloned from the marine bacteria Agrobacterium aurantiacus sp. nov. MK1 or Alcaligenes sp. PC-1, which are DNA strands comprising nucleotide sequences encoding the polypeptides having the amino acid sequences C-D in FIG. 2 (amino acid Nos. 1-162 in SEQ ID NO: 4) or C-D in FIG. 15 (amino acid Nos. 1-162 in SEQ ID NO: 11). The crtZ gene product (also referred to hereinafter as CrtZ) has an enzyme activity for adding a hydroxyl group to the 3-carbon atom of the β-ionone ring, and one of the specific examples is an enzyme activity for synthesizing zeaxanthin with use of β-carotene as a substrate by way of β-cryptoxanthin (see FIG. 11). In addition, the crtZ gene product also has an enzyme activity for adding a hydroxyl group to the 3-carbon atom of the 4-keto-β-ionone ring, and one of the specific examples is an enzyme activity for synthesizing astaxanthin with canthaxanthin as a substrate by way of phoenicoxanthin (see FIG. 11). In this connection, the polypeptide having the latter enzyme activity and the DNA strand encoding the polypeptide have not hitherto been reported. Moreover, CrtZ of Agrobacterium and Alcaligenes showed a high homology with CrtZ of Erwinia uredovora (57% and 58% identity), respectively, at an amino acid sequence level. Also, a high homology of 90% identity at an amino acid sequence level was shown between the CrtZ of Agrobacterium and Alcaligenes.
Lycopene-cyclizing Enzyme Gene (crtY) The DNA strand encoding the amino acid sequence substantially from E to F of FIGS. 3 and 4 (amino acid Nos. 1-386 in SEQ ID NO: 6) is a gene encoding a lycopene-cyclizing enzyme (referred to hereinafter as crtY). A typical example of the gene is the crtY gene cloned from the marine bacterium Agrobacterium aurantiacus sp. nov. MK1, which is the DNA strand comprising the nucleotide sequence encoding the polypeptide having the amino acid sequence E-F in FIGS. 3 and 4. The crtY gene product (also referred to hereinafter as CrtY) has an enzyme activity for synthesizing β-carotene with lycopene as a substrate (see FIG. 11). It is possible to allow a microorganism such as Escherichia coli or the like to produce lycopene by using a carotenoid biosynthesis genes of a non-photosynthetic bacterium Erwinia, that is the crtE, crtB and crtI genes of Erwinia give a microorganism such as Escherichia coli or the like a lycopene biosynthesis ability (see FIG. 10, and Laid-Open Publication of WO91/13078). Thus, the substrate of the CrtY of Agrobacterium is supplied by the crt gene group of Erwinia, so that when the crtY of Agrobacterium is introduced into a microorganism such as Escherichia coli or the like containing the crt gene group, it is possible to allow the microorganism to produce β-carotene.
Bacteriological Properties of Marine Bacteria The marine bacteria Agrobacterium aurantiacus sp. nov. MK1 and Alcaligenes sp. PC-1 as the sources of the xanthophyll synthetic genes show the following bacteriological properties.
Form and size of bacterium: rod, 0.9 μm�1.2 μm;
Reduction of nitrate: positive:
Growth range: pH, 5-9; temperature, 10-40� C.:
Xanthophyll Synthetic Gene Cluster of the Other Marine Bacteria It has hitherto been reported that 16 marine bacteria have an ability to synthesize ketocarotenoids such as astaxanthin and the like (Yokoyama, A., Izumida, H., Miki, W., "Marine bacteria produced astaxanthin", 10th International Symposium on Carotenoids, Abstract, CL11-3, 1993). If either of the crt genes of the aforementioned marine bacteria Agrobacterium aurantiacus sp. nov. MK-1 or Alcaligenes sp. PC-1 is used as a probe, the gene cluster playing a role of the biosynthesis of ketocarotenoids such as astaxanthin and the like should be obtained from the other astaxanthin producing marine bacteria by using the homology of the genes. In fact, the present inventors have successfully obtained the crtW and crtZ genes as the strongly hybridizing DNA fragments from the chromosomal DNA of Alcaligenes PC-1 with use of a DNA fragment containing crtW and crtZ of Ag. aurantiacus sp. nov. MK1 as a probe (see Examples as for the details). Furthermore, when Alteromonas SD-402 was selected from the remaining 14 marine bacteria having an astaxanthin synthetic ability and a chromosomal DNA was prepared therewith and subjected to the Southern hybridization experiment with a DNA fragment containing crtW and crtZ of Ag. aurantiacus sp. nov. MK1, the probe hybridized with the bands derived from the chromosomal DNA of the marine bacteria. The DNA strands according to the present invention also include a DNA strand which hybridizes with the DNA strands (2), (4), (6), (8), (11), (13), (15), (17), (20), (22), (24) and (26).
Acquisition of DNA Strands Although one of the methods for obtaining the DNA strand having a nucleotide sequence which encodes the amino acid sequence of each enzyme described above is to chemically synthesize at least a part of the strand length according to the method for synthesizing a nucleic acid, it is believed more preferable than the chemical synthetic method to obtain the DNA strand by using the total DNA having been digested with an appropriate restriction enzyme to prepare a library in Escherichia coli, from which library the DNA strand is obtained by the methods conventionally used in the art of genetic engineering such as a hybridization method with an appropriate probe (see the xanthophyll synthetic gene cluster of the other marine bacteria).
Transformation of an Microorganism such as Escherichia coli and Gene Expression A variety of xanthophylls can be prepared by introducing the present DNA strands described above an appropriate microorganism such as a bacterium, for example Escherichia coli, Zymomonas mobilis and Agrobacterium tumefaciens, and a yeast, for example Saccharomyces cerivisiae.
The procedure or method for introducing and expressing the foreign gene in a microorganism such as Escherichia coli or the like comprises the ones usually used in the art of genetic engineering in addition to those described below in the present invention and may be carried out according to the procedure or method (see, e.g., "Vectors for Cloning Genes", Methods in Enzymology, 216, p. 469-631, 1992, Academic Press, and "Other Bacterial Systems", Methods in Enzymology, 204, p. 305-636, 1991, Academic Press).
<Escherichia coli>
The method for introducing foreign genes into Escherichia coli includes several efficient methods such as the Hanahan's method and the rubidium method, and the foreign genes may be introduced according to these methods (see, for example, Sambrook, J., Fritsch, E. F., Maniatis, T., "Molecular Cloning--A Laboratory Manual", Cold Spring Harbor Laboratory Press, 1989). While foreign genes in Escherichia coli may be expressed according to the conventional methods (see, for example, "Molecular Cloning--A Laboratory Manual"), the expression can be carried out for example with a vector for Escherichia coli having a lac promoter in the pUC or pBluescript series. The present inventors have used a vector pBluescrip II SK or KS for Escherichia coli having a lac promoter and the like to insert the crtW, crtZ and crtY genes of Agrobacterium aurantiacus sp. nov. MK1 and the crtW and crtZ genes of Alcaligenes sp. PC-1 and allowed to express these genes in Escherichia coli.
The method for introducing foreign genes into yeast Saccharomyces cerivisiae includes the methods which have already been established such as the lithium method and the like, and the introduction may be carried out according to these methods (see, for example, Ed. Yuichi Akiyama, compiled by Bio-industry Association, "New Biotechnology of Yeast", published by IGAKU SHUPPAN CENTER). Foreign genes can be expressed in yeast by using a promoter and a terminator such as PGK and GPD to construct an expression cassette in which the foreign gene is inserted between the promoter and the terminator so that transcription is led through, and inserting the expression cassette into a vector such as the YRp system which is a multi-copy vector for yeast having the ARS sequence of the yeast chromosome as the replication origin, the YEp system which is a multi-copy vector for yeast having the replication origin of the 2 μm DNA of yeast, and the YIp system which is a vector for integrating a yeast chromosome having no replication origin of yeast (see "New Biotechnology of Yeast", published by IGAKU SHUPPAN CENTER, ibid.; NIPPON NOGEI-KAGAKU KAI ABC Series "Genetic Engineering for Producing Materials", published by ASAKURA SHOTEN; and Yamano, S., Ishii, T., Nakagawa, M., Ikenaga, H., Misawa, N., "Metabolic Engineering for Production of β-carotene and lycopene in Saccharomyces cerevisiae", Biosci. Biotech. Biochem., 58, p. 1112-1114, 1994).
Foreign genes can be introduced into an ethanol-producing bacterium Zymomonas mobilis by the conjugal transfer method which is common to Gram-negative bacteria, and the foreign genes can be expressed by using a vector pZA22 for Zymomonas mobilis (see Katsumi Nakamura, "Molecular Breeding of Zymomonas mobilis", Nippon Nogei-Kagaku Kaishi, 63, p. 1016-1018, 1989; and Misawa, N., Yamano, S., Ikanaga, H., "Production of β-Carotene in Zymomonas mobilis and Agrobacterium tumefaciens by Introduction of the Biosynthesis Genes from Erwinia uredovora", Appl. Environ. Microbiol., 57, p.1847-1849, 1991).
Production of Xanthophylls by Microorganisms The gene cluster for the synthesis of ketocarotenoids such as astaxanthin derived from a marine bacterium can be introduced and expressed by the procedure or method described above for introducing and expressing an foreign gene in a microorganism.
Farnesyl pyrophosphate (FPP) is a substrate which is common not only to carotenoids but also to other terpenoids such as sesquiterpenes, triterpenes, sterols, hopanols and the like. In general, microorganisms synthesize terpenoids even if they cannot synthesize carotenoids, so that all of the microorganisms should basically have FPP as an intermediate metabolite. Furthermore, the carotenoid synthesis gene cluster of a non-photosynthetic bacterium Erwinia has an ability to synthesize the substrates of the crt gene products of Agrobacterium aurantiacus sp. nov. MK1 or Alcaligenes sp. PC-1 by using FPP as a substrate (see FIG. 10). The present inventors have already confirmed that when the group of crt genes of Erwinia is introduced into not only Escherichia coli but also the aforementioned microorganisms, that is the yeast Saccharomyces cerevisiae, the ethanol producing bacterium Zymomonas mobilis, or the plant pathogenic bacterium Agrobacterium tumefaciens, carotenoids such as β-carotene and the like can be produced, as was expected, by these microorganisms (Yamano, S., Ishii, T., Nakagawa, M., Ikenaga, H., Misawa, N., "Metabolic Engineering for Production of β-Carotene and Lycopene in Saccharomyces cerevisiae", Biosci. Biotech. Biochem., 58, p. 1112-1114, 1994; Misawa, N., Yamano, S., Ikenaga, H., "Production of β-Carotene in Zymomonas mobilis and Agrobacterium tumefaciens by Introduction of the Biosynthetic Genes from Erwinia uredovora", Appl. Environ. Microbiol., 57, p. 1847-1849, 1991; and Japanese Patent Application No. 58786/1991 (Japanese Patent Application No. 53255/1990) by the present inventors: "DNA Strands useful for the Synthesis of Carotenoids").
A plasmid pACCAR16ΔcrtX that a fragment containing the crtE, crtB, crtI and crtY genes of Erwinia uredovora has been inserted into the Escherichia coli vector pACYC184 and a plasmid pPC17-3 that a fragment containing the crtW gene of Alcaligenes PC-1 has been inserted into the Escherichia coli vector pBluescript II SK+ were introduced into Escherichia coli JM101 and cultured to the stationary phase to collect bacterial cells and to extract carotenoid pigments. The extracted pigments comprised 40% of canthaxanthin and 50% of echinenone. The remainder. comprised 10% of unreacted β-carotene.
<Production of Astaxanthin and 4-ketozeaxanthin>
A plasmid pACCAR25ΔcrtX that a fragment containing the crtE, crtB, crtI, crtY and crtZ genes of Erwinia uredovora has been inserted into the Escherichia coli vector pACYC184 and a plasmid pPC17-3 that a fragment containing the crtW gene of Alcaligenes PC-1 has been inserted into the Escherichia coli vector pBluescript II SK+ were introduced into Escherichia coli JM101 and cultured to the stationary phase to collect bacterial cells and to extract carotenoid pigments. The yield of the extracted pigments was about 1 mg of astaxanthin and 4-ketozeaxanthin, respectively based on 2 liters of the culture solution.
<Production of Astaxanthin and Phoenicoxanthin>
Deposition of Microorganisms Microorganisms as the gene sources of the DNA strands of the present invention and Escherichia coli carrying the isolated genes (the DNA strands of the present invention) have been deposited in The National Institute of Bioscience and Human Technology, Agency of Industrial Science and Technology.
Entrusted Date: Dec. 20, 1993.
Deposition No: FERM BP-4505.
(iii) Alcaligense sp. PC-1
Entrusted Date: Jul. 27, 1994.
Example 1 Preparation of Chromosomal DNA Chromosomal DNAs were prepared from three marine bacterial strains, i.e. Agrobacterium aurantiacus sp. nov. MK1, Alcaligenes sp. PC-1, and Alteromonas SD-402 (Yokoyama, A., Izumida, H., Miki, W., "Marine bacteria produced astaxanthin", 10th International Symposium on Carotenoids, Abstract, CL11-3, 1993). After each of these marine bacteria was grown in 200 ml of a culture medium (a culture medium prepared according to the instruction of "Marine Broth" manufactured by DIFCO) at 25� C. for 4 days to the stationary phase, the bacterial cells were collected, washed with a TES buffer (20 mM Tris, 10 mM EDTA, 0.1 M NaCl, pH 8), subjected to heat treatment at 68� C. for 15 minutes, and suspended into the solution I (50 mM glucose, 25 mM Tris, 10 mM EDTA, pH 8) containing 5 mg/ml of lysozyme (manufactured by SEIKAGAKU KOGYO) and 100 μg/ml of RNase A (manufactured by Sigma). After incubation of the suspension at 37� C. for 1 hour, Proteinase K (manufactured by Boehringer-Mannheim) was added and the mixture was incubated at 37� C. for 10 minutes. After SARCOSIL (N-lauroylsarcosine Na, manufactured by Sigma) was then added at the final concentration of 1% and the mixture was sufficiently mixed, it was incubated at 37� C. for several hours. The mixture was extracted several times with phenol/chloroform, and ethanol in a two-time amount was added slowly. Chromosomal DNA thus deposited was wound around a glass rod, rinsed with 70% ethanol and dissolved in 2 ml of a TE buffer (10 mM Tris, 1 mM EDTA, pH 8) to prepare a chromosomal DNA solution.
After the removal of the BstEII (1235)-Eco521 (4926) fragment from a plasmid pCAR16 having a carotenoid synthesis gene cluster except the crtZ gene of Erwinia uredovora (Misawa, N., Nakagawa, M., Kobayashi, K., Yamano, S., Izawa, Y., Nakamura, K., Harashima, K., "Elucidation of the Erwinia uredovora Carotenoid Biosynthetic Pathway by Functional Analysis of Gene Porducts expressed in Escherichia coli", J. Bacteriol., 172, p. 6704-6712, 1990; and Japanese Patent Application No. 58786/1991 (Japanese Patent Application No. 53255/1990): "DNA Strands useful for the Synthesis of Carotenoids"), a 2.3 kb Asp718 (KpnI)-EcoRI fragment containing the crtE and crtB genes required for the production of phytoenes was cut out. This fragment was then inserted into the EcoRV site of the E. coli vector pACYC184 to give an aimed plasmid (pACCRT-EB). The bacterium E. coli containing pACCRT-EB exhibits resistance to an antibiotic chloramphenicol (Cmr) and produces phytoenes (Linden, H., Misawa, N., Chamovitz, D., Pecker, I., Hirschberg, J., Sandmann, G., "Functional Complementation in Escherichia coli of Different Phytoene Desaturase Genes and Analysis of Accumulated Carotenes", Z. Naturforsch., 46c, 1045-1051, 1991).
After the crtX gene was inactivated by subjecting a plasmid pCAR16 having a carotenoid synthesis gene cluster except the crtZ gene of Erwinia uredovora to digestion with restriction enzyme BstEII, the Klenow fragment treatment and the ligation reaction, a 6.0 kb Asp718 (KpnI)-EcoRI fragment containing crtE, crtY, crtI and crtB genes required for the production of β-carotene was cut out. This fragment was then inserted into the EcoRV site of the E. coli vector pACYC184 to give an aimed plasmid (referred to hereinafter as pACCAR16ΔcrtX). The bacterium E. coli containing pACCAR16ΔcrtX exhibits Cmr and produces β-carotene. In this connection, the restriction enzyme and enzymes used for genetic manipulation have been purchase from TAKARA SHUZO (K.K.) or Boehringer-Mannheim.
As a result, in cosmid libraries having the simple Escherichia coli (beige) or the phytoene-producing Escherichia coli (beige) with pACCRT-EB as a host, no colonies with changed color were obtained notwithstanding the screening of a ten thousand or more of the colonies for respective libraries. On the other hand, in cosmid libraries having the lycopene-producing Escherichia coli (light red) with pACCRT-EIB or the β-carotene-producing. Escherichia coli (yellow) with pACCAR16ΔcrtX as a host, colonies exhibiting orange have appeared in a proportion of one strain to several hundred colonies, respectively. Most of these transformed Escherichia coli strains which exhibits orange contained plasmid pJB8 in which about 40 kb partially digested Sau3AI fragments were cloned. It is also understood from the fact that no colonies with changed color appeared in cosmid libraries having the simple Escherichia coli or the phytoene-producing Escherichia coli with pACCRT-EB as a host, that Escherichia coli having an ability of producing a carotenoid synthetic intermediate of the later steps of at least phytoene should be used as a host for the purpose of expression-cloning the xanthophyll synthesis gene cluster from the chromosomal DNA of Agrobacterium aurantiacus sp. nov. MK1.
Example 5 Determination of the Nucleotide Sequence in the Orange Pigment Synthesis Gene Cluster A 3.9 kb EcoRI inserted fragment prepared from pAK9 was inserted into the EcoRI site of the Escherichia coli vector pBluescrip II SK+ to give two plasmids (pAK91 and pAK92) with the opposite directions of the fragment to the vector. The restriction enzyme map of one of the plasmids (pAK92) is illustrated in FIG. 12. When pAK92 was introduced into the lycopene-producing Escherichia coli, orange colonies were obtained as a result of the synthesis of astaxanthin (Example 6). However, no ability for synthesizing new pigments was afforded even if pAK91 was introduced into the lycopene-producing Escherichia coli. It was thus considered that the pigment synthesis gene cluster in the plasmid pAK92 has the same direction as that of the lac promoter of the vector. Next, each of a 2.7 kb PstI fragment obtained by the PstI digestion of pAK91, a 2.9 kb BamHI fragment obtained by the BamHI digestion of pAK92, and 2.3 kb and 1.6 kb SalI fragments obtained by the SalI digestion of pAK92 was cloned into the vector pBluescrip II SK-. The restriction maps of plasmids referred to as pAK94, pAK96, pAK98, pAK910, pAK93, and pAK95 are illustrated in FIG. 12. The plasmids pAK94, pAK96, pAK98 and pAK910 have the pigment synthesis gene cluster in the same direction as that of the lac promoter of the vector, while the plasmids pAK93 and pAK95 have the pigment synthesis gene cluster in the opposite direction to that of the promoter.
The DNA sequence was determined by preparing deletion mutants of the 2.9 kb BamHI fragment from the normal and opposite directions and determining the sequence using clones having various lengths of deletions. The deletion mutants were prepared from the four plasmids pAK96, pAK98, pAK93 and pAK95 according to the following procedure: Each of the plasmids, 10 μg, was decomposed with SacI and XbaI and extracted with phenol/chloroform to recover DNA by ethanol precipitation. Each of DNA was dissolved in 100 μl of ExoIII buffer (50 mM Tris-HCl, 100 mM NaCl, 5 mM MgCl2, 10 mM 2-mercaptoethanol, pH 8.0), 180 units of ExoIII nuclease was added, and the mixture was maintained at 37� C. A 10 μl portion was sampled at every 1. minute, and two samples were transferred into a tube in which 20 μl of MB buffer (40 mM sodium acetate, 100 mM NaCl, 2 mM ZnCl2, 10% glycerol, pH 4.5) is contained and which is placed on ice. After completion of the sampling, five tubes thus obtained were maintained at 65� C. for 10 minutes to inactivate the enzyme, five units of mung bean nuclease were added, and the mixtures were maintained at 37� C. for 30 minutes. After the reaction, five DNA fragments different from each other in the degrees of deletion were recovered for each plasmid by agarose gel electrophoresis. The DNA fragments thus recovered was blunt ended with the Klenow fragment, subjected to the ligation reaction at 16� C. overnight, and Escherichia coli JM109 was transformed. A single stranded DNA was prepared from each of various clones thus obtained with a helper phage M13K07, and subjected to the sequence reaction with a fluorescent primer cycle-sequence kit available from Applied Biosystem (K.K.), and the DNA sequence was determined with an automatic sequencer.
The DNA sequence comprising 2886 base pairs (bp) thus obtained is illustrated in FIGS. 5-9 (SEQ ID NO: 7). As a result of examining an open reading frame having a ribosome binding site in front of the initiation codon, three open reading frames which can encode the corresponding proteins (A-B (nucleotide positions 229-864 of SEQ ID NO: 7), C-D (nucleotide positions 864-1349), E-F (nucleotide positions 1349-2506) in FIGS. 5-9) were found at the positions where the three xanthophyll synthesis genes crtW, crtZ and crtY are expected to be present. For the two open reading frames of A-B and E-F, the initiating codon is GTG, and for the remaining open reading frame C-D, it is ATG.
Example 6 Identification of the Orange Pigment The lycopene-producing Escherichia coli JM101 having pAK92 or pAK96 introduced thereinto (Escherichia coli (pACCRT-EIB, pAK92 or pAK96); exhibiting orange) or the β-carotene-producing Escherichia coli JM101 having pAK94 or pAK96K (FIG. 12) introduced thereinto (Escherichia coli (pACCAR16ΔcrtX, pAK94 or pAK96K); exhibiting orange) was cultured in 4 liters of a 2YT culture medium (1.6% trypton, 1% yeast extract, 0.5% NaCl) containing 150 μg/ml of ampicillin (Ap, manufactured by Meiji Seika) and 30 μg/ml of chloramphenicol (Cm, manufactured by Sankyo) at 37� C. for 18 hours. Bacterial cells collected from the culture solution was extracted with 600 ml of acetone, concentrated, extracted twice with 400 ml of chloroform/methanol (9/1), and concentrated to dryness. Then, thin layer chromatography (TLC) was conducted by dissolving the residue in a small amount of chloroform/methanol (9/1) and developing on a silica gel plate for preparative TLC manufactured by Merck with chloroform/methanol (15/1). The original orange pigment was separated into three spots at the Rf values of 0.72, 0.82 and 0.91 by TLC. The pigment of the darkest spot at Rf 0.72 corresponding to 50% of the total amount of orange pigment and the pigment of secondly darker spot at Rf 0.82 were scratched off from the TLC plate, dissolved in a small amount of chloroform/methanol (9/1) or methanol, and chromatographed on a Sephadex LH-20 column (15�300 mm) with an eluent of chloroform/methanol (9/1) or methanol to give purified materials in a yield of 3 mg (Rf 0.72) and 2 mg (Rf 0.82), respectively.
It has been elucidated from the results of the UV-visible, 1 H-NMR and FD-MS (m/e 596) spectra that the pigment at Rf 0.72 has the same planar structure as that of astaxanthin. When the pigment was dissolved in diethyl ether:2-propanol:ethanol (5:5:2) to measure the CD spectrum, it was proved to have stereochemical configuration of 3S, 3'S, and thus identified as astaxanthin; see FIG. 11 for the structural formula). Also, the pigment at Rf 0.82 was identified as phoenicoxanthin (see FIG. 11 for the structural formula) from the results of its UV-visible, 1 H-NMR and FD-MS (m/e 580) spectra. In addition, the pigment at 0.91 was canthaxanthin (Example 7(2)).
The zeaxanthin producing Escherichia coli was prepared according to the following procedure. That is to say, the plasmid pCAR25 having total carotenoid synthesis gene cluster of Er. uredorora (Misawa, N., Nakagawa, M., Kobayashi, K., Yamano, S., Izawa, Y., Nakamura, K., Harashima, K., "Elucidation of the Erwinia uredovora Carotenoid Biosynthetic Pathway by Functional Analysis of Gene Products expressed in Escherichia coli", J. Bacteriol., 172, p. 6704-6712, 1990; and Japanese Patent Application No. 58786/1991 (Japanese Patent Application No. 53255/1990): "DNA Strands useful for the Synthesis of Carotenoids") was digested with restriction enzyme BstEII, and subjected to the Klenow fragment treatment and ligation reation to inactivate the crtX gene by reading frame shift, and then a 6.5 kb Asp718 (KpnI)-EcoRI fragment containing the crtE, crtY, crtI, crtB and crtZ genes required for producing zeaxanthin was cut out. This fragment was then inserted into the EcoRV site of the Escherichia coli vector pACYC184 to give the aimed plasmid (referred to hereinafter as pACCAR25ΔcrtX).
The zeaxanthin-producing Escherichia coli JM101 having pAK910 or pAK916 (FIG. 12) introduced thereinto. (Escherichia coli (pACCAR25ΔcrtX, pAK910 or pAK916); exhibiting orange) was cultured in 2 liters of a 2YT culture medium containing 150 μg/ml of Ap and 30 μg/ml of Cm at 37� C. for 18 hours. Bacterial cells collected from the culture solution was extracted with 300 ml of acetone, concentrated, extracted twice with 200 ml of chloroform/methanol (9/1), and concentrated to dryness. Then, thin layer chromatography (TLC) was conducted by dissolving the residue in a small amount of chloroform/methanol (9/1) and developing on a silica gel plate for preparative TLC manufactured by Merck with chloroform/methanol (15/1). The original orange pigment was separated into three spots at the Rf values of 0.54 (46%), 0.72 (53%) and 0.91 (1%) by TLC. The pigment at Rf 0.54 was scratched off from the TLC plate, dissolved in a small amount of chloroform/methanol (9/1) or methanol, and chromatographed on a Sephadex LH-20 column (15�300 mm) with an eluent of chloroform/methanol (9/1) or methanol to give a purified material in a yield of 1.5 mg.
This material was identified as 4-ketozeaxanthin (see FIG. 11 for the structural formula) since its UV-visible spectrum, FD-MS spectrum (m/e 582) and mobility in silica gel TLC (developed with chloroform/methanol (15/1)) accorded perfectly with those of the standard sample of 4-ketozeaxanthin (purified from Agrobacterium aurantiacus sp. nov. MK1; Japanese Patent Application No. 70335/1993). In addition, the pigments at Rf 0.72 and 0.91 are astaxanthin (Example 6) and canthaxanthin (Example 7 (2)), respectively.
The β-carotene producing Escherichia coli JM101 having pAK910 or pAK916 introduced thereinto (Escherichia coli (pACCAR16ΔcrtX, pAK910 or pAK916); exhibiting orange) was cultured in 2 liters of a 2YT culture medium containing 150 μg/ml of Ap and 30 μg/ml of Cm at 37� C. for 18 hours. Bacterial cells collected from the culture solution was extracted with 300 ml of acetone, concentrated, extracted twice with 200 ml of chloroform/methanol (9/1), and concentrated to dryness. Then, thin layer chromatography (TLC) was conducted by dissolving the residue in a small amount of chloroform/methanol (9/1) and developing on a silica gel plate for preparative TLC manufactured by Merck with chloroform/methanol (50/1). The pigment of the darkest spot corresponding to 94% of the total amount of orange pigments was scratched of f from the TLC plate, dissolved in a small amount of chloroform/methanol (9/1) or chloroform/methanol (1/1), and chromatographed on a Sephadex LH-20 column (15�300 mm) with an eluent of chloroform/methanol (9/1) or chloroform/methanol (1/1) to give a purified material in a yield of 3 mg.
The β-carotene-producing Escherichia coli JM101 having pAK96NK introduced thereinto (Escherichia coli (pACCAR16ΔcrtX, pAK96NK); exhibiting yellow) was cultured in 2 liters of a 2YT culture medium containing 150 μg/ml of Ap and 30 μg/ml of Cm at 37� C. for 18 hours. Bacterial cells collected from the culture solution was extracted with 300 ml of acetone, concentrated, extracted twice with 200 ml of chloroform/methanol (9/1), and concentrated to dryness. Then, thin layer chromatography (TLC) was conducted by dissolving the residue in a small amount of chloroform/methanol (9/1) and developing on a silica gel plate for preparative TLC manufactured by Merck with chloroform/methanol (9/1). The pigment of the darkest spot corresponding to 87% of the total amount of yellow pigments was scratched off from the TLC plate, dissolved in a small amount of chloroform/methanol (9/1) or methanol, and chromatographed on a Sephadex LH-20 column (15�300 mm) with an eluent of chloroform/methanol (9/1) or methanol to give a purified material in a yield of 3 mg.
It has been elucidated that this material has the same planar structure as that of zeaxanthin since its UV-visible, 1 H-NMR, FD-MS (m/e 568) spectra and mobility in silica gel TLC (Rf 0.59 on developing with chloroform/methanol (9/1)) accorded perfectly with those of the standard sample of zeaxanthin (manufactured by BASF). When the pigment was dissolved in diethyl ether:2-propanol:ethanol (5:5:2) to measure the CD spectrum, it was proved to have a stereochemical configuration of 3R, 3'R, and thus identified as zeaxanthin (see FIG. 11 for the structural formula). Also, the pigment corresponding to 13% of the total yellow pigments found in the initial extract was considered β-cryptoxanthin (see FIG. 11 for the structural formula) on the basis of its UV-visible spectrum, mobility in silica gel TLC (Rf 0.80 on developing with chloroform/methanol (9/1)), and mobility in HPLC with NOVA PACK HR 6μ C18 (3.9�300 mm; manufactured by Waters) (RT 19 minutes on developing at a flow rate of 1.0 ml/min with acetonitrile/methanol/2-propanol (90/6/4)).
The lycopene-producing Escherichia coli JM101 having pAK98 introduced thereinto (Escherichia coli (pACCRT-EIB, pAK98); exhibiting yellow) was cultured in 2 liters of a 2YT culture medium containing 150 μg/ml of Ap and 30 μg/ml of Cm at 37� C. for 18 hours. Bacterial cells collected from the culture solution was extracted with 300 ml of acetone, concentrated, and extracted twice with 200 ml of hexane. The hexane layer was concentrated and chromatographed on a silica gel column (15�300 mm) with an eluent of hexane/ethyl acetate (50/1) to give 3 mg of a purified material.
It is apparent from the results of Example 6 that among the 3.9 kb fragment contained in pAK9 (Example 4) or pAK92, all of the genes required for the synthesis of astaxanthin from lycopene is contained in the 2.9 kb BamHI fragment at the right side (pAK96, FIG. 12). Thus, the 1.0 kb fragment at the left side is not needed. Unique NcoI and KpnI sites are present within the 2.9 kb BamHI fragment of pAK96. It is found from the results of Example 7 (3) that the 1.4 kb fragment (pAK96NK) between the NcoI and KpnI sites has a hydroxyl group-introducing enzyme activity but has no keto group-introducing enzyme activity. Canthaxanthin can also be synthesized from β-carotene with the 2.9 kb BamHI fragment from which a fragment of the right side from unique SalI site between the NcoI and KpnI sites had been removed (pAK910) or with the 2.9 kb BamHI fragment from which a fragment of the right side from the HincII site positioned at the left side of the SalI site had been removed (pAK916), but activity for synthesizing canthaxanthin from β-carotene disappeared in the 2.9 kb BamHI fragment of pAK96 from which a fragment of the right side from the NcoI site left of the HincII site had been removed. On the other hand, even if a fragment of the left side from unique BglII site which is present leftward within the 0.9 kb BamHI-HincII fragment of pAK916 was removed, similar activity to that of the aforementioned BamHI-HincII fragment (pAK916) was observed. It is thus considered that a gene encoding a keto group-introducing enzyme having an enzyme activity for synthesizing canthaxanthin from β-carotene as a substrate is present within the 0.74 kb BglII-HincII fragment of pAK916, and the aforementioned NcoI site is present within this gene. As a result of determining the nucleotide sequence, an open reading frame which corresponds to the gene and has a ribosome binding site just in front of the initiation codon was successfully detected, it was then designated as the crtW gene. The nucleotide sequence of the crtW gene and the encoded amino acid sequence are illustrated in FIG. 1 (SEQ ID NOS: 1-2).
The crtW gene product (CrtW) of Agrobacterium aurantiacus sp. nov. MK1 has an enzyme activity for converting a methylene group at the 4-position of a β-ionone ring into a keto group, and one of the specific examples is an enzyme activity for synthesizing canthaxanthin from β-carotene as a substrate by way of echinenone (Example 7 (2); see FIG. 11). Furthermore, the crtW gene product also has an enzyme activity for converting a methylene group at the 4-position of a 3-hydroxy-β-ionone ring into a keto group, and one of the specific examples is an enzyme activity for synthesizing astaxanthin from zeaxanthin as a substrate by way of 4-ketozeaxanthin (Example 7 (1); see FIG. 11). In addition, polypeptides having such enzyme activities and DNA strands encoding these polypeptides have not hitherto been known, and the polypeptides and the DNA strands encoding these polypeptides have no overall homology to any polypeptides or DNA strands having been hitherto known. Also, no such. informations have hitherto been described that a methylene group of not only a β-ionone ring and a 3-hydroxy-β-ionone ring but also the other compounds is directly converted into a keto group with an enzyme.
Unique SalI site is present within the 2.9 kb BamHI fragment of pAK96. When the 2.9 kb BamHI fragment is cut into two fragments at the SalI site, these two fragments (pAK910 and pAK98) have no hydroxyl group-introducing activity. That is to say, the left fragment (pAK910) has only a keto group-introducing enzyme activity (Example 7 (2)), and the right fragment (pAK98) has only a lycopene-cyclizing enzyme activity (Example 7 (4)). On the other hand, when a 1.4 kb NcoI-KpnI fragment (pAK96NK) containing the aforementioned SalI site is introduced into a β-carotene-producing Escherichia coli, zeaxanthin is synthesized by way of β-cryptoxanthin (Example 7 (3)). It is thus considered that a gene encoding a hydroxyl group-introducing enzyme which has an enzyme activity for synthesizing zeaxanthin from β-carotene as a substrate is present within the 1.4 kb NcoI-KpnI fragment of pAK96NK, and the aforementioned SalI site is present within this gene. As a result of determining the nucleotide sequence, an open reading frame which corresponds to the gene and has a ribosome binding site just in front of the initiation codon was successfully detected, it was then referred to as the crtZ gene. The nucleotide sequence of the crtZ gene and the encoded amino acid sequence are illustrated in FIG. 2 (SEQ ID NOS: 3-4).
The crtZ gene product (CrtZ) of Agrobacterium aurantiacus sp. nov. MK1 has an enzyme activity for adding a hydroxyl group to the 3-carbon of a β-ionone ring, and one of the specific examples is an enzyme activity for synthesizing zeaxanthin from β-carotene as a substrate by way of β-cryptoxanthin (Example 7 (3); see FIG. 11). Furthermore, the crtZ gene product also has an enzyme. activity for adding a hydroxyl group to the 3-carbon of a 4-keto-β-ionone ring, and one of the specific examples is an enzyme activity for synthesizing astaxanthin from canthaxanthin as a substrate by way of phoenicoxanthin (Example 6; see FIG. 11). In addition, polypeptides having the latter enzyme activity and DNA strands encoding these polypeptides have not hitherto been known. Also, the CrtZ of Agrobacterium showed significant homology to the CrtZ of Erwinia uredovora (identity of 57%) at the level of amino acid sequence.
Astaxanthin can be synthesized from β-carotene with the 2.9 kb BamHI fragment from which a fragment of the right side from a KpnI site had been removed (pAK96K) or with the 2.9 kb BamHI fragment from which a fragment right from the PstI site which is placed further right of the KpnI site had been removed (pAK94) (Example 6), but astaxanthin cannot be synthesized from lycopene. On the other hand, when a 1.6 kb SalI fragment (pAK98), which contains a right fragment from unique SalI site present further left than the aforementioned KpnI site within the 2.9 kb BamHI fragment, was introduced into lycopene-producing Escherichia coli, β-carotene was synthesized (Example 7 (4)). It is thus considered that a gene encoding lycopene cyclase that has an enzyme activity for synthesizing β-carotene from lycopene as a substrate is present within the 1.6 kb SalI fragment of pAK98, and this gene is present over a range of the KpnI site and the PstI site. As a result of determining the nucleotide sequence, an open reading frame which corresponds to the gene and has a ribosome binding site just in front of the initiation codon was successfully detected, it was then referred to as the crtY gene. The nucleotide sequence of the crtY gene and the amino acid sequence to be encoded are illustrated in FIGS. 3-4 (SEQ ID NO: 3).
Example 9 Southern Blotting Analysis with the Chromosomal DNA of the Other Marine Bacteria Examination was conducted whether a region exhibiting homology with the isolated crtW and crtZ is obtained from a chromosomal DNAs of the other marine microorganisms. The chromosomal DNAs of Alcaligenes sp. PC-1 and Alteromonas sp. SD-402 prepared in Example 1 were digested with restriction enzymes BamHI and PstI, and separated by agarose gel electrophoresis. All of the DNA fragments thus separated were denaturated with an alkali solution of 0.5 N NaOH and 1.5 M NaCl, and transferred on a nylon membrane filter over an overnight period. The nylon membrane filter on which DNAs had been adsorbed was dipped in a hybridization solution (6�Denhardt, 5�SSC, 100 μg/ml ssDNA), and pre-hybridization was conducted at 60� C. for 2 hours. Next, the 1.5 kb DNA fragment cut out from pAK96K with BalI, which contains crtW and crtY, was labelled with a Mega prime� DNA labelling systems (Amersham) and [α-32 P]dCTP (�110 TBq/mmol) and added to the aforementioned prehybridization solution to conduct hybridization at 60� C. for 16 hours.
It was found that even if a plasmid having a 0.72 kb BstEII-EcoRV fragment positioned at the right side of the PstI fragment had been removed (referred to as pPC17, FIG. 19) was introduced into the β-carotene-producing Escherichia coli, the transformant of Escherichia coli synthesized astaxanthin and the like (Example 12), same as in the case of E. coli into which pPC11 was introduced, so that the nucleotide sequence of the 1.63 kb PstI-BstEII fragment in pPC17 was determined.
Deletion mutants were prepared with pPC17 and pPC12 according to the following procedure. A 10 μg portion of each of pPC17 and pPC12 was digested with KpnI and HindIII or KpnI and EcoRI, extracted with phenol/chloroform, and DNA was recovered by precipitation with ethanol. Each of DNAs was dissolved in 100 μl of ExoIII buffer (50 mM Tris-HCl, 100 mM NaCl, 5 mM MgCl2, 10 mM 2-mercaptoethanol, pH 8.0), 180 units of ExoIII nuclease was added, and the mixture was maintained at 37� C. A 10 μl portion was sampled at every 1 minute, and two samples were transferred into a tube in which 20 μl of an MB buffer (40 mM sodium acetate, 100 mM NaCl, 2 mM ZnCl2, 10% glycerol, pH 4.5) is contained and which is placed on ice. After completion of the sampling, five tubes thus obtained were maintained at 65� C. for 10 minutes to inactivate the enzyme, five units of mung bean nuclease were added, and the mixture was maintained at 37� C. for 30 minutes. After the reaction, ten DNA fragments different from each other in the degrees of deletion were recovered for each plasmid by agarose gel electrophoresis. The DNA fragments thus recovered were blunt ended with the Klenow fragment, subjected to the ligation reaction at 16� C. overnight, and Escherichia coli JM109 was transformed. A single stranded DNA was prepared from each of various clones thus obtained with a helper phage M13K07, and subjected to the sequence reaction with a fluorescent primer cycle-sequence kit available from Applied Biosystem (K.K.), and the DNA sequence was determined with an automatic sequencer.
The material was identified as zeaxanthin, since all of the data of its UV-visible, FD-MS (m/e 568) spectra and mobility in TLC (developed with chloroform/methanol (9/1)) accorded with those of the standard sample of zeaxanthin (Example 7 (3)). In addition, the pigment of which amount corresponds to 10% of the total amount of the orange pigments observed in the initial extract was considered to be β-cryptoxanthin from its UV-visible spectrum, mobility in silica gel TLC (developed with chloroform/methanol (9/1)), and mobility in HPLC with NOVA PACK HR 6μ C18 (3.9�300 mm; manufactured by Waters) (developed with acetonitrile/methanol/2-propanol (90/6/4)) (Example 7 (3)).
It is apparent from the results of Examples 11 and 12 (1) that all of the genes required for the synthesis of astaxanthin from β-carotene among the 2.35 kb PstI fragment contained in pPC11 is contained in the 1.63 kb PstI-BstEII fragment (pPC17, FIG. 19) in the left side. Thus, the 0.72 kb BstEII-PstI fragment in the right side is not needed. Unique SmaI and SalI sites are present within the 1.63 kb PstI-BstEII fragment of pPC17 (FIG. 19). It is confirmed by the pigment analysis with a β-carotene-producing Escherichia coli having the deletion plasmids introduced thereinto that the keto group-introducing enzyme activity was lost when the 0.65 kb and 0.69 kb fragments at the left side from SmaI and SalI sites were removed. It. was also confirmed by the pigment analysis with β-carotene-producing Escherichia coli having the plasmid introduced thereinto that the plasmid having a 0.69 kb PstI-SalI fragment positioned at the left side of the 1.63 kb PstI-BstEII fragment inserted into the PstI-SalI site of pBluescript SK+ has no keto group-introducing enzyme activity. On the other hand, the deletion plasmid pPC17-3 (FIG. 19) in which deletion from the BstEII end at the right end to the nucleotide No. 1162 (nucleotide position 1162 in SEQ ID NO: 12) occurred has a keto group-introducing enzyme activity (Example 12 (1), (2)), so that it is considered a gene encoding a keto group-introducing enzyme having an enzyme activity for synthesizing canthaxanthin or astaxanthin with a substrate of β-carotene or zeaxanthin is present in the 1162 bp fragment in pPC17-3, and the aforementioned SmaI and SalI sites are present within this gene. As a result of determining the nucleotide sequence, an open reading frame which corresponds to the gene and has a ribosome binding site just in front of the initiation codon was successfully detected, so that it was referred to as the crtW gene. The nucleotide sequence of the crtW gene and the encoded amino acid sequence are illustrated in FIGS. 13-14 (SEQ ID NOS: 8-9).
The crtW gene product (CrtW) of Alcaligenes sp. PC-1 has an enzyme activity for converting a methylene group at the 4-position of a β-ionone ring into a keto group, and one of the specific examples is an enzyme activity for synthesizing canthaxanthin from β-carotene as a substrate by way of echinenone (Example 12 (2); see FIG. 11). Furthermore, the crtW gene product also has an enzyme activity for converting a methylene group at the 4-position of a 3-hydroxy-β-ionone ring into a keto group, and one Qf the specific examples is an enzyme activity for synthesizing astaxanthin from zeaxanthin as a substrate by way of 4-ketozeaxanthin (Example 12 (1); see FIG. 11). In addition, polypeptides having such enzyme activities and DNA strands encoding these polypeptides have not hitherto been known, and the polypeptides and the DNA strands encoding these polypeptides have no total homology to any polypeptides or DNA strands having been hitherto known. Also, the crtW gene products (CrtW) of Agrobacterium aurantiacus sp. nov. MK1 and Alcaligenes sp. PC-1 share high homology (identity of 83%) at the level of amino acid sequence, and the functions of both enzymes are the same. The amino acid sequence in the region of 17% having no identity among these amino acid sequences is considered not so significant to the functions of the enzyme. It is thus considered particularly in this region that a little amount of substitution by the other amino acids, deletion, or addition of the other amino acids will not afftect the enzyme activity.
All of the genes rerquired for the synthesis of astaxanthin from β-carotene is contained in the 1.63 kb PstI-BstEII fragment (FIG. 19) of pPC17. One SalI site is present within the 1.63 kb PstI-BstEII fragment of pPC17. It is apparent from the results of Example 12 (3) that a hydroxyl group-introducing enzyme activity is present in a fragment at the right side from the SalI site. It is thus understood that the hydroxyl group-introducing enzyme activity is present in the 0.94 kb SalI-BstEII fragment which is the right fragment in the 1.63 kb PstI-BstEII fragment. As a result of determining the nucleotide sequence, an open reading frame which corresponds to the gene and has a ribosome binding site just in front of the initiation codon was successfully detected, it was referred to as the crtZ gene. The nucleotide sequence of the crtZ gene and the encoded amino acid sequence are illustrated in FIG. 15 (SEQ ID NOS: 10-11).
The crtZ gene product (CrtZ) of Alcaligenes sp. PC-1 has an enzyme activity for adding a hydroxyl group to the 3-carbon of a β-ionone ring, and one of the specific examples is an enzyme activity for synthesizing zeaxanthin from β-carotene as a substrate by way of β-cryptoxanthin (Example 12 (3); see FIG. 11). Furthermore, the crtZ gene product also has an enzyme activity for adding a hydroxyl group to the 3-carbon of a 4-keto-β-ionone ring, and one of the specific examples is an enzyme activity for synthesizing astaxanthin from canthaxanthin as a substrate by way of phoenicoxanthin (Example 12 (1); see FIG. 11). In addition, polypeptides having the latter enzyme activity and DNA strands encoding these polypeptides have not hitherto been known. Also, the CrtZ of Alcaligenes sp. PC-1 showed significant homology to the CrtZ of Erwinia uredovora (identity of 58%) at the level of amino acid sequence. In addition, the crtZ gene products (CrtZ) of Agrobacterium aurantiacus sp. nov. MK1 and Alcaligenes sp. PC-1 have high homology (identity of 90%) at the level of amino acid sequence, and the functions of both enzymes are the same. The amino acid sequence in the region of 10% having no identity among these amino acid sequences is considered not so significant to the functions of the enzyme. It is thus considered particularly in this region that a little amount of substitution by the other amino acids, deletion, or addition of the other amino acids will not afftect the enzyme activity.
It has been elucidated by our studies with carotenoid synthesis genes of the epiphytic bacterium Erwinia or the photosynthetic bacterium Rhodobacter that carotenoid biosynthesis enzymes generally act by recognizing the half of a carotenoid molecule as a substrate. By way of example, the lycopene cyclase gene of Erwinia, crtY, recognizes the halves of the lycopene molecule to cyclize it. When the phytoene desaturase gene crtI of Rhodobacter was used for the synthesis of neurosporene in place of lycopene in Escherichia coli and crtY of Erwinia was allowed to work on it, the crtY gene product recognizes the half molecular structure common to lycopene to produce a half cyclized β-zeacarotene (Linden, H., Misawa, N., Chamovits, D., Pecher, I., Hirschberg, J., Sandmann, G., "Functional Complementation in Escherichia coli of Different Phytoene Desaturase Genes and Analysis of Accumulated Carotenes", Z. Naturforsch., 46c, p. 1045-1051, 1991). Also, in the present invention, when CrtW is allowed to work on β-carotene or zeaxanthin, echinenone or 4-ketozeaxanthin in which one keto group has been introduced is first synthesized, and when CrtZ is allowed to work on β-carotene or canthaxanthin, β-cryptoxanthin or phoenicoxanthin in which one hydroxyl group has been introduced is first synthesized. It can be considered because these enzymes recognize the half molecule of the substrate. Thus, while Escherichia coli having the crtE, crtB, crtI and crtY genes of Erwinia and the crtZ gene of a marine bacterium produces zeaxanthin as described above, β-cryptoxanthin which is β-carotene having one hydroxyl group introduced thereinto can be detected as an intermediate metabolite. It can be thus considered that if CrtW is present, 3'-hydroxyechinenone or 3-hydroxyechinenone can be synthesized from β-cryptoxanthin as a substrate, and that phoenicoxanthin can be further synthesized by the action of CrtW on these intermediates, The present inventors have not identified these ketocarotenoids in the culture solutions, and the reason is considered to be that only a trace amount of these compounds is present under the conditions carried out in the present experiments. In fact, it was described that 3-hydroxyechinenone or 3'-hydroxyechinenone was detected as a minor intermediate metabolite of astaxanthin in a marine bacterium Agrobacterium aurantiacus sp. nov. MK1 as a gene source (Akihiro Yokoyama ed., "For the biosynthesis of astaxanthin in marine bacteria", Nippon Suisan Gakkai, Spring Symposium, 1994, Abstract, p. 252, 1994). It can be considered from the above descriptions that minor metabolic pathways shown in FIG. 20 are also present in addition to the main metabolic pathways of astaxanthin shown in FIG. 11.
__________________________________________________________________________#             SEQUENCE LISTING   - -  - - (1) GENERAL INFORMATION:   - -    (iii) NUMBER OF SEQUENCES: 12   - -  - - (2) INFORMATION FOR SEQ ID NO:1:   - -      (i) SEQUENCE CHARACTERISTICS:       (A) LENGTH: 639 base - #pairs       (B) TYPE: nucleic acid       (C) STRANDEDNESS: double       (D) TOPOLOGY: linear   - -     (ix) FEATURE:       (A) NAME/KEY: CDS       (B) LOCATION: 1..636   - -     (ix) FEATURE:       (A) NAME/KEY: mat-- - #peptide       (B) LOCATION: 1..636   - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:1:   - - GTG CAT GCG CTG TGG TTT CTG GAC GCA GCG GC - #G CAT CCC ATC CTGGCG       48  Val His Ala Leu Trp Phe Leu Asp Ala Ala Al - #a His Pro Ile Leu Ala   1               5 - #                 10 - #                 15  - - ATC GCA AAT TTC CTG GGG CTG ACC TGG CTG TC - #G GTC GGA TTG TTC ATC 96 Ile Ala Asn Phe Leu Gly Leu Thr Trp Leu Se - #r Val Gly Leu Phe Ile         20     - #             25     - #             30  - - ATC GCG CAT GAC GCG ATG CAC GGG TCG GTG GT - #G CCG GGG CGT CCG CGC144 Ile Ala His Asp Ala Met His Gly Ser Val Va - #l Pro Gly Arg Pro Arg     35         - #         40         - #         45  - - GCC AAT GCG GCG ATG GGC CAG CTT GTC CTG TG - #G CTG TAT GCC GGA TTT192 Ala Asn Ala Ala Met Gly Gln Leu Val Leu Tr - #p Leu Tyr Ala Gly Phe 50             - #     55             - #     60  - - TCG TGG CGC AAG ATG ATC GTC AAG CAC ATG GC - #C CAT CAC CGC CAT GCC240 Ser Trp Arg Lys Met Ile Val Lys His Met Al - #a His His Arg His Ala  65                 - # 70                 - # 75                 - # 80  - - GGA ACC GAC GAC GAC CCC GAT TTC GAC CAT GG - #C GGC CCG GTC CGC TGG288 Gly Thr Asp Asp Asp Pro Asp Phe Asp His Gl - #y Gly Pro Val Arg Trp             85 - #                 90 - #                 95  - - TAC GCC CGC TTC ATC GGC ACC TAT TTC GGC TG - #G CGC GAG GGG CTG CTG336 Tyr Ala Arg Phe Ile Gly Thr Tyr Phe Gly Tr - #p Arg Glu Gly Leu Leu        100      - #           105      - #           110  - - CTG CCC GTC ATC GTG ACG GTC TAT GCG CTG AT - #C CTT GGG GAT CGC TGG384 Leu Pro Val Ile Val Thr Val Tyr Ala Leu Il - #e Leu Gly Asp Arg Trp    115          - #       120          - #       125  - - ATG TAC GTG GTC TTC TGG CCG CTG CCG TCG AT - #C CTG GCG TCG ATC CAG432 Met Tyr Val Val Phe Trp Pro Leu Pro Ser Il - #e Leu Ala Ser Ile Gln130              - #   135              - #   140  - - CTG TTC GTG TTC GGC ACC TGG CTG CCG CAC CG - #C CCC GGC CAC GAC GCG480 Leu Phe Val Phe Gly Thr Trp Leu Pro His Ar - #g Pro Gly His Asp Ala 145                 1 - #50                 1 - #55                 1 -#60   - - TTC CCG GAC CGC CAC AAT GCG CGG TCG TCG CG - #G ATC AGC GAC CCCGTG      528  Phe Pro Asp Arg His Asn Ala Arg Ser Ser Ar - #g Ile Ser Asp Pro Val            165  - #               170  - #               175  - - TCG CTG CTG ACC TGC TTT CAC TTT GGC GGT TA - #T CAT CAC GAA CAC CAC576 Ser Leu Leu Thr Cys Phe His Phe Gly Gly Ty - #r His His Glu His His        180      - #           185      - #           190  - - CTG CAC CCG ACG GTG CCG TGG TGG CGC CTG CC - #C AGC ACC CGC ACC AAG624 Leu His Pro Thr Val Pro Trp Trp Arg Leu Pr - #o Ser Thr Arg Thr Lys    195          - #       200          - #       205  - - GGG GAC ACC GCA TGA           - #                  - #    - #   639 Gly Asp Thr Ala210  - -  - - (2) INFORMATION FOR SEQ ID NO:2:  - -      (i) SEQUENCE CHARACTERISTICS:      (A) LENGTH: 212 amino - #acids      (B) TYPE: amino acid      (D) TOPOLOGY: linear  - -     (ii) MOLECULE TYPE: protein  - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:  - - Val His Ala Leu Trp Phe Leu Asp Ala Ala Al - #a His Pro Ile Leu Ala   1               5 - #                 10 - #                 15  - - Ile Ala Asn Phe Leu Gly Leu Thr Trp Leu Se - #r Val Gly Leu Phe Ile         20     - #             25     - #             30  - - Ile Ala His Asp Ala Met His Gly Ser Val Va - #l Pro Gly Arg Pro Arg     35         - #         40         - #         45  - - Ala Asn Ala Ala Met Gly Gln Leu Val Leu Tr - #p Leu Tyr Ala Gly Phe 50             - #     55             - #     60  - - Ser Trp Arg Lys Met Ile Val Lys His Met Al - #a His His Arg His Ala  65                 - # 70                 - # 75                 - # 80  - - Gly Thr Asp Asp Asp Pro Asp Phe Asp His Gl - #y Gly Pro Val Arg Trp             85 - #                 90 - #                 95  - - Tyr Ala Arg Phe Ile Gly Thr Tyr Phe Gly Tr - #p Arg Glu Gly Leu Leu        100      - #           105      - #           110  - - Leu Pro Val Ile Val Thr Val Tyr Ala Leu Il - #e Leu Gly Asp Arg Trp    115          - #       120          - #       125  - - Met Tyr Val Val Phe Trp Pro Leu Pro Ser Il - #e Leu Ala Ser Ile Gln130              - #   135              - #   140  - - Leu Phe Val Phe Gly Thr Trp Leu Pro His Ar - #g Pro Gly His Asp Ala 145                 1 - #50                 1 - #55                 1 -#60   - - Phe Pro Asp Arg His Asn Ala Arg Ser Ser Ar - #g Ile Ser Asp ProVal             165  - #               170  - #               175  - - Ser Leu Leu Thr Cys Phe His Phe Gly Gly Ty - #r His His Glu His His        180      - #           185      - #           190  - - Leu His Pro Thr Val Pro Trp Trp Arg Leu Pr - #o Ser Thr Arg Thr Lys    195          - #       200          - #       205  - - Gly Asp Thr Ala210  - -  - - (2) INFORMATION FOR SEQ ID NO:3:  - -      (i) SEQUENCE CHARACTERISTICS:      (A) LENGTH: 489 base - #pairs      (B) TYPE: nucleic acid      (C) STRANDEDNESS: double      (D) TOPOLOGY: linear  - -     (ix) FEATURE:      (A) NAME/KEY: CDS      (B) LOCATION: 1..486  - -     (ix) FEATURE:      (A) NAME/KEY: mat-- - #peptide      (B) LOCATION: 1..486  - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3:  - - ATG ACC AAT TTC CTG ATC GTC GTC GCC ACC GT - #G CTG GTG ATG GAG TTG 48 Met Thr Asn Phe Leu Ile Val Val Ala Thr Va - #l Leu Val Met Glu Leu   1               5 - #                 10 - #                 15  - - ACG GCC TAT TCC GTC CAC CGC TGG ATC ATG CA - #C GGC CCC CTG GGC TGG 96 Thr Ala Tyr Ser Val His Arg Trp Ile Met Hi - #s Gly Pro Leu Gly Trp         20     - #             25     - #             30  - - GGC TGG CAC AAG TCC CAC CAC GAG GAA CAC GA - #C CAC GCG CTG GAA AAG144 Gly Trp His Lys Ser His His Glu Glu His As - #p His Ala Leu Glu Lys     35         - #         40         - #         45  - - AAC GAC CTG TAC GGC CTG GTC TTT GCG GTG AT - #C GCC ACG GTG CTG TTC192 Asn Asp Leu Tyr Gly Leu Val Phe Ala Val Il - #e Ala Thr Val Leu Phe 50             - #     55             - #     60  - - ACG GTG GGC TGG ATC TGG GCG CCG GTC CTG TG - #G TGG ATC GCC TTG GGC240 Thr Val Gly Trp Ile Trp Ala Pro Val Leu Tr - #p Trp Ile Ala Leu Gly  65                 - # 70                 - # 75                 - # 80  - - ATG ACT GTC TAT GGG CTG ATC TAT TTC GTC CT - #G CAT GAC GGG CTG GTG288 Met Thr Val Tyr Gly Leu Ile Tyr Phe Val Le - #u His Asp Gly Leu Val             85 - #                 90 - #                 95  - - CAT CAG CGC TGG CCG TTC CGT TAT ATC CCG CG - #C AAG GGC TAT GCC AGA336 His Gln Arg Trp Pro Phe Arg Tyr Ile Pro Ar - #g Lys Gly Tyr Ala Arg        100      - #           105      - #           110  - - CGC CTG TAT CAG GCC CAC CGC CTG CAC CAT GC - #G GTC GAG GGG CGC GAC384 Arg Leu Tyr Gln Ala His Arg Leu His His Al - #a Val Glu Gly Arg Asp    115          - #       120          - #       125  - - CAT TGC GTC AGC TTC GGC TTC ATC TAT GCG CC - #C CCG GTC GAC AAG CTG432 His Cys Val Ser Phe Gly Phe Ile Tyr Ala Pr - #o Pro Val Asp Lys Leu130              - #   135              - #   140  - - AAG CAG GAC CTG AAG ATG TCG GGC GTG CTG CG - #G GCC GAG GCG CAG GAG480 Lys Gln Asp Leu Lys Met Ser Gly Val Leu Ar - #g Ala Glu Ala Gln Glu 145                 1 - #50                 1 - #55                 1 -#60   - - CGC ACG TGA              - #                  - #- #        489 Arg Thr  - -  - - (2) INFORMATION FOR SEQ ID NO:4:  - -      (i) SEQUENCE CHARACTERISTICS:      (A) LENGTH: 162 amino - #acids      (B) TYPE: amino acid      (D) TOPOLOGY: linear  - -     (ii) MOLECULE TYPE: protein  - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4:  - - Met Thr Asn Phe Leu Ile Val Val Ala Thr Va - #l Leu Val Met Glu Leu   1               5 - #                 10 - #                 15  - - Thr Ala Tyr Ser Val His Arg Trp Ile Met Hi - #s Gly Pro Leu Gly Trp         20     - #             25     - #             30  - - Gly Trp His Lys Ser His His Glu Glu His As - #p His Ala Leu Glu Lys     35         - #         40         - #         45  - - Asn Asp Leu Tyr Gly Leu Val Phe Ala Val Il - #e Ala Thr Val Leu Phe 50             - #     55             - #     60  - - Thr Val Gly Trp Ile Trp Ala Pro Val Leu Tr - #p Trp Ile Ala Leu Gly  65                 - # 70                 - # 75                 - # 80  - - Met Thr Val Tyr Gly Leu Ile Tyr Phe Val Le - #u His Asp Gly Leu Val             85 - #                 90 - #                 95  - - His Gln Arg Trp Pro Phe Arg Tyr Ile Pro Ar - #g Lys Gly Tyr Ala Arg        100      - #           105      - #           110  - - Arg Leu Tyr Gln Ala His Arg Leu His His Al - #a Val Glu Gly Arg Asp    115          - #       120          - #       125  - - His Cys Val Ser Phe Gly Phe Ile Tyr Ala Pr - #o Pro Val Asp Lys Leu130              - #   135              - #   140  - - Lys Gln Asp Leu Lys Met Ser Gly Val Leu Ar - #g Ala Glu Ala Gln Glu 145                 1 - #50                 1 - #55                 1 -#60   - - Arg Thr   - -  - - (2) INFORMATION FOR SEQ ID NO:5:   - -      (i) SEQUENCE CHARACTERISTICS:       (A) LENGTH: 1161 base - #pairs       (B) TYPE: nucleic acid       (C) STRANDEDNESS: double       (D) TOPOLOGY: linear   - -     (ix) FEATURE:       (A) NAME/KEY: CDS       (B) LOCATION: 1..1158   - -     (ix) FEATURE:       (A) NAME/KEY: mat-- - #peptide       (B) LOCATION: 1..1158   - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5:   - - GTG ACC CAT GAC GTG CTG CTG GCA GGG GCG GG - #C CTT GCC AAC GGGCTG       48  Val Thr His Asp Val Leu Leu Ala Gly Ala Gl - #y Leu Ala Asn Gly Leu   1               5 - #                 10 - #                 15  - - ATC GCC CTG GCG CTG CGC GCG GCG CGG CCC GA - #C CTG CGC GTG CTG CTG 96 Ile Ala Leu Ala Leu Arg Ala Ala Arg Pro As - #p Leu Arg Val Leu Leu         20     - #             25     - #             30  - - CTG GAC CAT GCC GCA GGA CCG TCA GAC GGC CA - #C ACC TGG TCC TGC CAC144 Leu Asp His Ala Ala Gly Pro Ser Asp Gly Hi - #s Thr Trp Ser Cys His     35         - #         40         - #         45  - - GAC CCC GAC CTG TCG CCG GAC TGG CTG GCG CG - #G CTG AAG CCC CTG CGC192 Asp Pro Asp Leu Ser Pro Asp Trp Leu Ala Ar - #g Leu Lys Pro Leu Arg 50             - #     55             - #     60  - - CGC GCC AAC TGG CCC GAC CAG GAG GTG CGC TT - #T CCC CGC CAT GCC CGG240 Arg Ala Asn Trp Pro Asp Gln Glu Val Arg Ph - #e Pro Arg His Ala Arg  65                 - # 70                 - # 75                 - # 80  - - CGG CTG GCC ACC GGT TAC GGG TCG CTG GAC GG - #G GCG GCG CTG GCG GAT288 Arg Leu Ala Thr Gly Tyr Gly Ser Leu Asp Gl - #y Ala Ala Leu Ala Asp             85 - #                 90 - #                 95  - - GCG GTG GTC CGG TCG GGC GCC GAG ATC CGC TG - #G GAC AGC GAC ATC GCC336 Ala Val Val Arg Ser Gly Ala Glu Ile Arg Tr - #p Asp Ser Asp Ile Ala        100      - #           105      - #           110  - - CTG CTG GAT GCG CAG GGG GCG ACG CTG TCC TG - #C GGC ACC CGG ATC GAG384 Leu Leu Asp Ala Gln Gly Ala Thr Leu Ser Cy - #s Gly Thr Arg Ile Glu    115          - #       120          - #       125  - - GCG GGC GCG GTC CTG GAC GGG CGG GGC GCG CA - #G CCG TCG CGG CAT CTG432 Ala Gly Ala Val Leu Asp Gly Arg Gly Ala Gl - #n Pro Ser Arg His Leu130              - #   135              - #   140  - - ACC GTG GGT TTC CAG AAA TTC GTG GGT GTC GA - #G ATC GAG ACC GAC CGC480 Thr Val Gly Phe Gln Lys Phe Val Gly Val Gl - #u Ile Glu Thr Asp Arg 145                 1 - #50                 1 - #55                 1 -#60   - - CCC CAC GGC GTG CCC CGC CCG ATG ATC ATG GA - #C GCG ACC GTC ACCCAG      528  Pro His Gly Val Pro Arg Pro Met Ile Met As - #p Ala Thr Val Thr Gln            165  - #               170  - #               175  - - CAG GAC GGG TAC CGC TTC ATC TAT CTG CTG CC - #C TTC TCT CCG ACG CGC576 Gln Asp Gly Tyr Arg Phe Ile Tyr Leu Leu Pr - #o Phe Ser Pro Thr Arg        180      - #           185      - #           190  - - ATC CTG ATC GAG GAC ACG CGC TAT TCC GAT GG - #C GGC GAT CTG GAC GAC624 Ile Leu Ile Glu Asp Thr Arg Tyr Ser Asp Gl - #y Gly Asp Leu Asp Asp    195          - #       200          - #       205  - - GAC GCG CTG GCG GCG GCG TCC CAC GAC TAT GC - #C CGC CAG CAG GGC TGG672 Asp Ala Leu Ala Ala Ala Ser His Asp Tyr Al - #a Arg Gln Gln Gly Trp210              - #   215              - #   220  - - ACC GGG GCC GAG GTC CGG CGC GAA CGC GGC AT - #C CTT CCC ATC GCG CTG720 Thr Gly Ala Glu Val Arg Arg Glu Arg Gly Il - #e Leu Pro Ile Ala Leu 225                 2 - #30                 2 - #35                 2 -#40   - - GCC CAT GAT GCG GCG GGC TTC TGG GCC GAT CA - #C GCG GCG GGG CCTGTT      768  Ala His Asp Ala Ala Gly Phe Trp Ala Asp Hi - #s Ala Ala Gly Pro Val            245  - #               250  - #               255  - - CCC GTG GGA CTG CGC GCG GGG TTC TTT CAT CC - #G GTC ACC GGC TAT TCG816 Pro Val Gly Leu Arg Ala Gly Phe Phe His Pr - #o Val Thr Gly Tyr Ser        260      - #           265      - #           270  - - CTG CCC TAT GCG GCA CAG GTG GCG GAC GTG GT - #G GCG GGT CTG TCC GGG864 Leu Pro Tyr Ala Ala Gln Val Ala Asp Val Va - #l Ala Gly Leu Ser Gly    275          - #       280          - #       285  - - CCG CCC GGC ACC GAC GCG CTG CGC GGC GCC AT - #C CGC GAT TAC GCG ATC912 Pro Pro Gly Thr Asp Ala Leu Arg Gly Ala Il - #e Arg Asp Tyr Ala Ile290              - #   295              - #   300  - - GAC CGG GCG CGC CGC GAC CGC TTT CTG CGC CT - #T TTG AAC CGG ATG CTG960 Asp Arg Ala Arg Arg Asp Arg Phe Leu Arg Le - #u Leu Asn Arg Met Leu 305                 3 - #10                 3 - #15                 3 -#20   - - TTC CGC GGC TGC GCG CCC GAC CGG CGC TAT AC - #C CTG CTG CAG CGGTTC     1008  Phe Arg Gly Cys Ala Pro Asp Arg Arg Tyr Th - #r Leu Leu Gln Arg Phe            325  - #               330  - #               335  - - TAC CGC ATG CCG CAT GGA CTG ATC GAA CGG TT - #C TAT GCC GGC CGG CTG    1056 Tyr Arg Met Pro His Gly Leu Ile Glu Arg Ph - #e Tyr Ala Gly Arg Leu        340      - #           345      - #           350  - - AGC GTG GCG GAT CAG CTG CGC ATC GTG ACC GG - #C AAG CCT CCC ATT CCC    1104 Ser Val Ala Asp Gln Leu Arg Ile Val Thr Gl - #y Lys Pro Pro Ile Pro    355          - #       360          - #       365  - - CTT GGC ACG GCC ATC CGC TGC CTG CCC GAA CG - #T CCC CTG CTG AAG GAA    1152 Leu Gly Thr Ala Ile Arg Cys Leu Pro Glu Ar - #g Pro Leu Leu Lys Glu370              - #   375              - #   380  - - AAC GCA TGA              - #                  - #- #       1161  Asn Ala  385   - -  - - (2) INFORMATION FOR SEQ ID NO:6:   - -      (i) SEQUENCE CHARACTERISTICS:       (A) LENGTH: 386 amino - #acids       (B) TYPE: amino acid       (D) TOPOLOGY: linear   - -     (ii) MOLECULE TYPE: protein   - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:6:   - - Val Thr His Asp Val Leu Leu Ala Gly Ala Gl - #y Leu Ala Asn GlyLeu    1               5 - #                 10 - #                 15  - - Ile Ala Leu Ala Leu Arg Ala Ala Arg Pro As - #p Leu Arg Val Leu Leu         20     - #             25     - #             30  - - Leu Asp His Ala Ala Gly Pro Ser Asp Gly Hi - #s Thr Trp Ser Cys His     35         - #         40         - #         45  - - Asp Pro Asp Leu Ser Pro Asp Trp Leu Ala Ar - #g Leu Lys Pro Leu Arg 50             - #     55             - #     60  - - Arg Ala Asn Trp Pro Asp Gln Glu Val Arg Ph - #e Pro Arg His Ala Arg  65                 - # 70                 - # 75                 - # 80  - - Arg Leu Ala Thr Gly Tyr Gly Ser Leu Asp Gl - #y Ala Ala Leu Ala Asp             85 - #                 90 - #                 95  - - Ala Val Val Arg Ser Gly Ala Glu Ile Arg Tr - #p Asp Ser Asp Ile Ala        100      - #           105      - #           110  - - Leu Leu Asp Ala Gln Gly Ala Thr Leu Ser Cy - #s Gly Thr Arg Ile Glu    115          - #       120          - #       125  - - Ala Gly Ala Val Leu Asp Gly Arg Gly Ala Gl - #n Pro Ser Arg His Leu130              - #   135              - #   140  - - Thr Val Gly Phe Gln Lys Phe Val Gly Val Gl - #u Ile Glu Thr Asp Arg 145                 1 - #50                 1 - #55                 1 -#60   - - Pro His Gly Val Pro Arg Pro Met Ile Met As - #p Ala Thr Val ThrGln             165  - #               170  - #               175  - - Gln Asp Gly Tyr Arg Phe Ile Tyr Leu Leu Pr - #o Phe Ser Pro Thr Arg        180      - #           185      - #           190  - - Ile Leu Ile Glu Asp Thr Arg Tyr Ser Asp Gl - #y Gly Asp Leu Asp Asp    195          - #       200          - #       205  - - Asp Ala Leu Ala Ala Ala Ser His Asp Tyr Al - #a Arg Gln Gln Gly Trp210              - #   215              - #   220  - - Thr Gly Ala Glu Val Arg Arg Glu Arg Gly Il - #e Leu Pro Ile Ala Leu 225                 2 - #30                 2 - #35                 2 -#40   - - Ala His Asp Ala Ala Gly Phe Trp Ala Asp Hi - #s Ala Ala Gly ProVal             245  - #               250  - #               255  - - Pro Val Gly Leu Arg Ala Gly Phe Phe His Pr - #o Val Thr Gly Tyr Ser        260      - #           265      - #           270  - - Leu Pro Tyr Ala Ala Gln Val Ala Asp Val Va - #l Ala Gly Leu Ser Gly    275          - #       280          - #       285  - - Pro Pro Gly Thr Asp Ala Leu Arg Gly Ala Il - #e Arg Asp Tyr Ala Ile290              - #   295              - #   300  - - Asp Arg Ala Arg Arg Asp Arg Phe Leu Arg Le - #u Leu Asn Arg Met Leu 305                 3 - #10                 3 - #15                 3 -#20   - - Phe Arg Gly Cys Ala Pro Asp Arg Arg Tyr Th - #r Leu Leu Gln ArgPhe             325  - #               330  - #               335  - - Tyr Arg Met Pro His Gly Leu Ile Glu Arg Ph - #e Tyr Ala Gly Arg Leu        340      - #           345      - #           350  - - Ser Val Ala Asp Gln Leu Arg Ile Val Thr Gl - #y Lys Pro Pro Ile Pro    355          - #       360          - #       365  - - Leu Gly Thr Ala Ile Arg Cys Leu Pro Glu Ar - #g Pro Leu Leu Lys Glu370              - #   375              - #   380  - - Asn Ala 385  - -  - - (2) INFORMATION FOR SEQ ID NO:7:  - -      (i) SEQUENCE CHARACTERISTICS:      (A) LENGTH: 2886 base - #pairs      (B) TYPE: nucleic acid      (C) STRANDEDNESS: double      (D) TOPOLOGY: linear  - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:7:  - - GGATCCGGCG ACCTTGCGGC GCTGCGCCGC GCGCCTTTGC TGGTGCCTGG GC -#CGGGTGGC     60   - - CAATGGTCGC AAGCAACGGG GATGGAAACC GGCGATGCGG GACTGTAGTC TG -#CGCGGATC    120   - - GCCGGTCCGG GGGACAAGAT GAGCGCACAT GCCCTGCCCA AGGCAGATCT GA -#CCGCCACC    180   - - AGCCTGATCG TCTCGGGCGG CATCATCGCC GCTTGGCTGG CCCTGCATGT GC -#ATGCGCTG    240   - - TGGTTTCTGG ACGCAGCGGC GCATCCCATC CTGGCGATCG CAAATTTCCT GG -#GGCTGACC    300   - - TGGCTGTCGG TCGGATTGTT CATCATCGCG CATGACGCGA TGCACGGGTC GG -#TGGTGCCG    360   - - GGGCGTCCGC GCGCCAATGC GGCGATGGGC CAGCTTGTCC TGTGGCTGTA TG -#CCGGATTT    420   - - TCGTGGCGCA AGATGATCGT CAAGCACATG GCCCATCACC GCCATGCCGG AA -#CCGACGAC    480   - - GACCCCGATT TCGACCATGG CGGCCCGGTC CGCTGGTACG CCCGCTTCAT CG -#GCACCTAT    540   - - TTCGGCTGGC GCGAGGGGCT GCTGCTGCCC GTCATCGTGA CGGTCTATGC GC -#TGATCCTT    600   - - GGGGATCGCT GGATGTACGT GGTCTTCTGG CCGCTGCCGT CGATCCTGGC GT -#CGATCCAG    660   - - CTGTTCGTGT TCGGCACCTG GCTGCCGCAC CGCCCCGGCC ACGACGCGTT CC -#CGGACCGC    720   - - CACAATGCGC GGTCGTCGCG GATCAGCGAC CCCGTGTCGC TGCTGACCTG CT -#TTCACTTT    780   - - GGCGGTTATC ATCACGAACA CCACCTGCAC CCGACGGTGC CGTGGTGGCG CC -#TGCCCAGC    840   - - ACCCGCACCA AGGGGGACAC CGCATGACCA ATTTCCTGAT CGTCGTCGCC AC -#CGTGCTGG    900   - - TGATGGAGTT GACGGCCTAT TCCGTCCACC GCTGGATCAT GCACGGCCCC CT -#GGGCTGGG    960   - - GCTGGCACAA GTCCCACCAC GAGGAACACG ACCACGCGCT GGAAAAGAAC GA -#CCTGTACG   1020   - - GCCTGGTCTT TGCGGTGATC GCCACGGTGC TGTTCACGGT GGGCTGGATC TG -#GGCGCCGG   1080   - - TCCTGTGGTG GATCGCCTTG GGCATGACTG TCTATGGGCT GATCTATTTC GT -#CCTGCATG   1140   - - ACGGGCTGGT GCATCAGCGC TGGCCGTTCC GTTATATCCC GCGCAAGGGC TA -#TGCCAGAC   1200   - - GCCTGTATCA GGCCCACCGC CTGCACCATG CGGTCGAGGG GCGCGACCAT TG -#CGTCAGCT   1260   - - TCGGCTTCAT CTATGCGCCC CCGGTCGACA AGCTGAAGCA GGACCTGAAG AT -#GTCGGGCG   1320   - - TGCTGCGGGC CGAGGCGCAG GAGCGCACGT GACCCATGAC GTGCTGCTGG CA -#GGGGCGGG   1380   - - CCTTGCCAAC GGGCTGATCG CCCTGGCGCT GCGCGCGGCG CGGCCCGACC TG -#CGCGTGCT   1440   - - GCTGCTGGAC CATGCCGCAG GACCGTCAGA CGGCCACACC TGGTCCTGCC AC -#GACCCCGA   1500   - - CCTGTCGCCG GACTGGCTGG CGCGGCTGAA GCCCCTGCGC CGCGCCAACT GG -#CCCGACCA   1560   - - GGAGGTGCGC TTTCCCCGCC ATGCCCGGCG GCTGGCCACC GGTTACGGGT CG -#CTGGACGG   1620   - - GGCGGCGCTG GCGGATGCGG TGGTCCGGTC GGGCGCCGAG ATCCGCTGGG AC -#AGCGACAT   1680   - - CGCCCTGCTG GATGCGCAGG GGGCGACGCT GTCCTGCGGC ACCCGGATCG AG -#GCGGGCGC   1740   - - GGTCCTGGAC GGGCGGGGCG CGCAGCCGTC GCGGCATCTG ACCGTGGGTT TC -#CAGAAATT   1800   - - CGTGGGTGTC GAGATCGAGA CCGACCGCCC CCACGGCGTG CCCCGCCCGA TG -#ATCATGGA   1860   - - CGCGACCGTC ACCCAGCAGG ACGGGTACCG CTTCATCTAT CTGCTGCCCT TC -#TCTCCGAC   1920   - - GCGCATCCTG ATCGAGGACA CGCGCTATTC CGATGGCGGC GATCTGGACG AC -#GACGCGCT   1980   - - GGCGGCGGCG TCCCACGACT ATGCCCGCCA GCAGGGCTGG ACCGGGGCCG AG -#GTCCGGCG   2040   - - CGAACGCGGC ATCCTTCCCA TCGCGCTGGC CCATGATGCG GCGGGCTTCT GG -#GCCGATCA   2100   - - CGCGGCGGGG CCTGTTCCCG TGGGACTGCG CGCGGGGTTC TTTCATCCGG TC -#ACCGGCTA   2160   - - TTCGCTGCCC TATGCGGCAC AGGTGGCGGA CGTGGTGGCG GGTCTGTCCG GG -#CCGCCCGG   2220   - - CACCGACGCG CTGCGCGGCG CCATCCGCGA TTACGCGATC GACCGGGCGC GC -#CGCGACCG   2280   - - CTTTCTGCGC CTTTTGAACC GGATGCTGTT CCGCGGCTGC GCGCCCGACC GG -#CGCTATAC   2340   - - CCTGCTGCAG CGGTTCTACC GCATGCCGCA TGGACTGATC GAACGGTTCT AT -#GCCGGCCG   2400   - - GCTGAGCGTG GCGGATCAGC TGCGCATCGT GACCGGCAAG CCTCCCATTC CC -#CTTGGCAC   2460   - - GGCCATCCGC TGCCTGCCCG AACGTCCCCT GCTGAAGGAA AACGCATGAA CG -#CCCATTCG   2520   - - CCCGCGGCCA AGACCGCCAT CGTGATCGGC GCAGGCTTTG GCGGGCTGGC CC -#TGGCCATC   2580   - - CGCCTGCAGT CCGCGGGCAT CGCCACCACC CTGGTCGAGG CCCGGGACAA GC -#CCGGCGGG   2640   - - CGCGCCTATG TCTGGCACGA TCAGGGCCAT CTCTTCGACG CGGGCCCGAC CG -#TCATCACC   2700   - - GACCCCGATG CGCTGAAAGA GCTGTGGGCC CTGACCGGGC AGGACATGGC GC -#GCGACGTG   2760   - - ACGCTGATGC CGGTCTCGCC CTTCTATCGG CTGATGTGGC CGGGCGGGAA GG -#TCTTCGAT   2820   - - TACGTGAACG AGGCCGATCC AGGGTCTGGG TCTTGCCGTG CCAGGTGAAG CT -#GTTGCCGT   2880   - - GGATCC                 - #                  - #                  -#         2886  - -  - - (2) INFORMATION FOR SEQ ID NO:8:  - -      (i) SEQUENCE CHARACTERISTICS:      (A) LENGTH: 729 base - #pairs      (B) TYPE: nucleic acid      (C) STRANDEDNESS: double      (D) TOPOLOGY: linear  - -     (ix) FEATURE:      (A) NAME/KEY: CDS      (B) LOCATION: 1..726  - -     (ix) FEATURE:      (A) NAME/KEY: mat-- - #peptide      (B) LOCATION: 1..726  - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:8:  - - ATG TCC GGA CGG AAG CCT GGC ACA ACT GGC GA - #C ACG ATC GTC AAT CTC 48 Met Ser Gly Arg Lys Pro Gly Thr Thr Gly As - #p Thr Ile Val Asn Leu   1               5 - #                 10 - #                 15  - - GGT CTG ACC GCC GCG ATC CTG CTG TGC TGG CT - #G GTC CTG CAC GCC TTT 96 Gly Leu Thr Ala Ala Ile Leu Leu Cys Trp Le - #u Val Leu His Ala Phe         20     - #             25     - #             30  - - ACG CTA TGG TTG CTA GAT GCG GCC GCG CAT CC - #G CTG CTT GCC GTG CTG144 Thr Leu Trp Leu Leu Asp Ala Ala Ala His Pr - #o Leu Leu Ala Val Leu     35         - #         40         - #         45  - - TGC CTG GCT GGG CTG ACC TGG CTG TCG GTC GG - #G CTG TTC ATC ATC GCG192 Cys Leu Ala Gly Leu Thr Trp Leu Ser Val Gl - #y Leu Phe Ile Ile Ala 50             - #     55             - #     60  - - CAT GAC GCA ATG CAC GGG TCC GTG GTG CCG GG - #G CGG CCG CGC GCC AAT240 His Asp Ala Met His Gly Ser Val Val Pro Gl - #y Arg Pro Arg Ala Asn  65                 - # 70                 - # 75                 - # 80  - - GCG GCG ATC GGG CAA CTG GCG CTG TGG CTC TA - #T GCG GGG TTC TCG TGG288 Ala Ala Ile Gly Gln Leu Ala Leu Trp Leu Ty - #r Ala Gly Phe Ser Trp             85 - #                 90 - #                 95  - - CCC AAG CTG ATC GCC AAG CAC ATG ACG CAT CA - #C CGG CAC GCC GGC ACC336 Pro Lys Leu Ile Ala Lys His Met Thr His Hi - #s Arg His Ala Gly Thr        100      - #           105      - #           110  - - GAC AAC GAT CCC GAT TTC GGT CAC GGA GGG CC - #C GTG CGC TGG TAC GGC384 Asp Asn Asp Pro Asp Phe Gly His Gly Gly Pr - #o Val Arg Trp Tyr Gly    115          - #       120          - #       125  - - AGC TTC GTC TCC ACC TAT TTC GGC TGG CGA GA - #G GGA CTG CTG CTA CCG432 Ser Phe Val Ser Thr Tyr Phe Gly Trp Arg Gl - #u Gly Leu Leu Leu Pro130              - #   135              - #   140  - - GTG ATC GTC ACC ACC TAT GCG CTG ATC CTG GG - #C GAT CGC TGG ATG TAT480 Val Ile Val Thr Thr Tyr Ala Leu Ile Leu Gl - #y Asp Arg Trp Met Tyr 145                 1 - #50                 1 - #55                 1 -#60   - - GTC ATC TTC TGG CCG GTC CCG GCC GTT CTG GC - #G TCG ATC CAG ATTTTC      528  Val Ile Phe Trp Pro Val Pro Ala Val Leu Al - #a Ser Ile Gln Ile Phe            165  - #               170  - #               175  - - GTC TTC GGA ACT TGG CTG CCC CAC CGC CCG GG - #A CAT GAC GAT TTT CCC576 Val Phe Gly Thr Trp Leu Pro His Arg Pro Gl - #y His Asp Asp Phe Pro        180      - #           185      - #           190  - - GAC CGG CAC AAC GCG AGG TCG ACC GGC ATC GG - #C GAC CCG TTG TCA CTA624 Asp Arg His Asn Ala Arg Ser Thr Gly Ile Gl - #y Asp Pro Leu Ser Leu    195          - #       200          - #       205  - - CTG ACC TGC TTC CAT TTC GGC GGC TAT CAC CA - #C GAA CAT CAC CTG CAT672 Leu Thr Cys Phe His Phe Gly Gly Tyr His Hi - #s Glu His His Leu His210              - #   215              - #   220  - - CCG CAT GTG CCG TGG TGG CGC CTG CCT CGT AC - #A CGC AAG ACC GGA GGC720 Pro His Val Pro Trp Trp Arg Leu Pro Arg Th - #r Arg Lys Thr Gly Gly 225                 2 - #30                 2 - #35                 2 -#40   - - CGC GCA TGA              - #                  - #- #        729 Arg Ala  - -  - - (2) INFORMATION FOR SEQ ID NO:9:  - -      (i) SEQUENCE CHARACTERISTICS:      (A) LENGTH: 242 amino - #acids      (B) TYPE: amino acid      (D) TOPOLOGY: linear  - -     (ii) MOLECULE TYPE: protein  - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:9:  - - Met Ser Gly Arg Lys Pro Gly Thr Thr Gly As - #p Thr Ile Val Asn Leu   1               5 - #                 10 - #                 15  - - Gly Leu Thr Ala Ala Ile Leu Leu Cys Trp Le - #u Val Leu His Ala Phe         20     - #             25     - #             30  - - Thr Leu Trp Leu Leu Asp Ala Ala Ala His Pr - #o Leu Leu Ala Val Leu     35         - #         40         - #         45  - - Cys Leu Ala Gly Leu Thr Trp Leu Ser Val Gl - #y Leu Phe Ile Ile Ala 50             - #     55             - #     60  - - His Asp Ala Met His Gly Ser Val Val Pro Gl - #y Arg Pro Arg Ala Asn  65                 - # 70                 - # 75                 - # 80  - - Ala Ala Ile Gly Gln Leu Ala Leu Trp Leu Ty - #r Ala Gly Phe Ser Trp             85 - #                 90 - #                 95  - - Pro Lys Leu Ile Ala Lys His Met Thr His Hi - #s Arg His Ala Gly Thr        100      - #           105      - #           110  - - Asp Asn Asp Pro Asp Phe Gly His Gly Gly Pr - #o Val Arg Trp Tyr Gly    115          - #       120          - #       125  - - Ser Phe Val Ser Thr Tyr Phe Gly Trp Arg Gl - #u Gly Leu Leu Leu Pro130              - #   135              - #   140  - - Val Ile Val Thr Thr Tyr Ala Leu Ile Leu Gl - #y Asp Arg Trp Met Tyr 145                 1 - #50                 1 - #55                 1 -#60   - - Val Ile Phe Trp Pro Val Pro Ala Val Leu Al - #a Ser Ile Gln IlePhe             165  - #               170  - #               175  - - Val Phe Gly Thr Trp Leu Pro His Arg Pro Gl - #y His Asp Asp Phe Pro        180      - #           185      - #           190  - - Asp Arg His Asn Ala Arg Ser Thr Gly Ile Gl - #y Asp Pro Leu Ser Leu    195          - #       200          - #       205  - - Leu Thr Cys Phe His Phe Gly Gly Tyr His Hi - #s Glu His His Leu His210              - #   215              - #   220  - - Pro His Val Pro Trp Trp Arg Leu Pro Arg Th - #r Arg Lys Thr Gly Gly 225                 2 - #30                 2 - #35                 2 -#40   - - Arg Ala   - -  - - (2) INFORMATION FOR SEQ ID NO:10:   - -      (i) SEQUENCE CHARACTERISTICS:       (A) LENGTH: 489 base - #pairs       (B) TYPE: nucleic acid       (C) STRANDEDNESS: double       (D) TOPOLOGY: linear   - -     (ix) FEATURE:       (A) NAME/KEY: CDS       (B) LOCATION: 1..486   - -     (ix) FEATURE:       (A) NAME/KEY: mat-- - #peptide       (B) LOCATION: 1..486   - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:10:   - - ATG ACG CAA TTC CTC ATT GTC GTG GCG ACA GT - #C CTC GTG ATG GAGCTG       48  Met Thr Gln Phe Leu Ile Val Val Ala Thr Va - #l Leu Val Met Glu Leu   1               5 - #                 10 - #                 15  - - ACC GCC TAT TCC GTC CAC CGC TGG ATT ATG CA - #C GGC CCC CTA GGC TGG 96 Thr Ala Tyr Ser Val His Arg Trp Ile Met Hi - #s Gly Pro Leu Gly Trp         20     - #             25     - #             30  - - GGC TGG CAC AAG TCC CAT CAC GAA GAG CAC GA - #C CAC GCG TTG GAG AAG144 Gly Trp His Lys Ser His His Glu Glu His As - #p His Ala Leu Glu Lys     35         - #         40         - #         45  - - AAC GAC CTC TAC GGC GTC GTC TTC GCG GTG CT - #G GCG ACG ATC CTC TTC192 Asn Asp Leu Tyr Gly Val Val Phe Ala Val Le - #u Ala Thr Ile Leu Phe 50             - #     55             - #     60  - - ACC GTG GGC GCC TAT TGG TGG CCG GTG CTG TG - #G TGG ATC GCC CTG GGC240 Thr Val Gly Ala Tyr Trp Trp Pro Val Leu Tr - #p Trp Ile Ala Leu Gly  65                 - # 70                 - # 75                 - # 80  - - ATG ACG GTC TAT GGG TTG ATC TAT TTC ATC CT - #G CAC GAC GGG CTT GTG288 Met Thr Val Tyr Gly Leu Ile Tyr Phe Ile Le - #u His Asp Gly Leu Val             85 - #                 90 - #                 95  - - CAT CAA CGC TGG CCG TTT CGG TAT ATT CCG CG - #G CGG GGC TAT TTC CGC336 His Gln Arg Trp Pro Phe Arg Tyr Ile Pro Ar - #g Arg Gly Tyr Phe Arg        100      - #           105      - #           110  - - AGG CTC TAC CAA GCT CAT CGC CTG CAC CAC GC - #G GTC GAG GGG CGG GAC384 Arg Leu Tyr Gln Ala His Arg Leu His His Al - #a Val Glu Gly Arg Asp    115          - #       120          - #       125  - - CAC TGC GTC AGC TTC GGC TTC ATC TAT GCC CC - #A CCC GTG GAC AAG CTG432 His Cys Val Ser Phe Gly Phe Ile Tyr Ala Pr - #o Pro Val Asp Lys Leu130              - #   135              - #   140  - - AAG CAG GAT CTG AAG CGG TCG GGT GTC CTG CG - #C CCC CAG GAC GAG CGT480 Lys Gln Asp Leu Lys Arg Ser Gly Val Leu Ar - #g Pro Gln Asp Glu Arg 145                 1 - #50                 1 - #55                 1 -#60   - - CCG TCG TGA              - #                  - #- #        489 Pro Ser  - -  - - (2) INFORMATION FOR SEQ ID NO:11:  - -      (i) SEQUENCE CHARACTERISTICS:      (A) LENGTH: 162 amino - #acids      (B) TYPE: amino acid      (D) TOPOLOGY: linear  - -     (ii) MOLECULE TYPE: protein  - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:11:  - - Met Thr Gln Phe Leu Ile Val Val Ala Thr Va - #l Leu Val Met Glu Leu   1               5 - #                 10 - #                 15  - - Thr Ala Tyr Ser Val His Arg Trp Ile Met Hi - #s Gly Pro Leu Gly Trp         20     - #             25     - #             30  - - Gly Trp His Lys Ser His His Glu Glu His As - #p His Ala Leu Glu Lys     35         - #         40         - #         45  - - Asn Asp Leu Tyr Gly Val Val Phe Ala Val Le - #u Ala Thr Ile Leu Phe 50             - #     55             - #     60  - - Thr Val Gly Ala Tyr Trp Trp Pro Val Leu Tr - #p Trp Ile Ala Leu Gly  65                 - # 70                 - # 75                 - # 80  - - Met Thr Val Tyr Gly Leu Ile Tyr Phe Ile Le - #u His Asp Gly Leu Val             85 - #                 90 - #                 95  - - His Gln Arg Trp Pro Phe Arg Tyr Ile Pro Ar - #g Arg Gly Tyr Phe Arg        100      - #           105      - #           110  - - Arg Leu Tyr Gln Ala His Arg Leu His His Al - #a Val Glu Gly Arg Asp    115          - #       120          - #       125  - - His Cys Val Ser Phe Gly Phe Ile Tyr Ala Pr - #o Pro Val Asp Lys Leu130              - #   135              - #   140  - - Lys Gln Asp Leu Lys Arg Ser Gly Val Leu Ar - #g Pro Gln Asp Glu Arg 145                 1 - #50                 1 - #55                 1 -#60   - - Pro Ser   - -  - - (2) INFORMATION FOR SEQ ID NO:12:   - -      (i) SEQUENCE CHARACTERISTICS:       (A) LENGTH: 1631 base - #pairs       (B) TYPE: nucleic acid       (C) STRANDEDNESS: double       (D) TOPOLOGY: linear   - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:12:   - - CTGCAGGCCG GGCCCGGTGG CCAATGGTCG CAACCGGCAG GACTGGAACA GG -#ACGGCGGG     60   - - CCGGTCTAGG CTGTCGCCCT ACGCAGCAGG AGTTTCGGAT GTCCGGACGG AA -#GCCTGGCA    120   - - CAACTGGCGA CACGATCGTC AATCTCGGTC TGACCGCCGC GATCCTGCTG TG -#CTGGCTGG    180   - - TCCTGCACGC CTTTACGCTA TGGTTGCTAG ATGCGGCCGC GCATCCGCTG CT -#TGCCGTGC    240   - - TGTGCCTGGC TGGGCTGACC TGGCTGTCGG TCGGGCTGTT CATCATCGCG CA -#TGACGCAA    300   - - TGCACGGGTC CGTGGTGCCG GGGCGGCCGC GCGCCAATGC GGCGATCGGG CA -#ACTGGCGC    360   - - TGTGGCTCTA TGCGGGGTTC TCGTGGCCCA AGCTGATCGC CAAGCACATG AC -#GCATCACC    420   - - GGCACGCCGG CACCGACAAC GATCCCGATT TCGGTCACGG AGGGCCCGTG CG -#CTGGTACG    480   - - GCAGCTTCGT CTCCACCTAT TTCGGCTGGC GAGAGGGACT GCTGCTACCG GT -#GATCGTCA    540   - - CCACCTATGC GCTGATCCTG GGCGATCGCT GGATGTATGT CATCTTCTGG CC -#GGTCCCGG    600   - - CCGTTCTGGC GTCGATCCAG ATTTTCGTCT TCGGAACTTG GCTGCCCCAC CG -#CCCGGGAC    660   - - ATGACGATTT TCCCGACCGG CACAACGCGA GGTCGACCGG CATCGGCGAC CC -#GTTGTCAC    720   - - TACTGACCTG CTTCCATTTC GGCGGCTATC ACCACGAACA TCACCTGCAT CC -#GCATGTGC    780   - - CGTGGTGGCG CCTGCCTCGT ACACGCAAGA CCGGAGGCCG CGCATGACGC AA -#TTCCTCAT    840   - - TGTCGTGGCG ACAGTCCTCG TGATGGAGCT GACCGCCTAT TCCGTCCACC GC -#TGGATTAT    900   - - GCACGGCCCC CTAGGCTGGG GCTGGCACAA GTCCCATCAC GAAGAGCACG AC -#CACGCGTT    960   - - GGAGAAGAAC GACCTCTACG GCGTCGTCTT CGCGGTGCTG GCGACGATCC TC -#TTCACCGT   1020   - - GGGCGCCTAT TGGTGGCCGG TGCTGTGGTG GATCGCCCTG GGCATGACGG TC -#TATGGGTT   1080   - - GATCTATTTC ATCCTGCACG ACGGGCTTGT GCATCAACGC TGGCCGTTTC GG -#TATATTCC   1140   - - GCGGCGGGGC TATTTCCGCA GGCTCTACCA AGCTCATCGC CTGCACCACG CG -#GTCGAGGG   1200   - - GCGGGACCAC TGCGTCAGCT TCGGCTTCAT CTATGCCCCA CCCGTGGACA AG -#CTGAAGCA   1260   - - GGATCTGAAG CGGTCGGGTG TCCTGCGCCC CCAGGACGAG CGTCCGTCGT GA -#TCTCTGAT   1320   - - CCCGGCGTGG CCGCATGAAA TCCGACGTGC TGCTGGCAGG GGCCGGCCTT GC -#CAACGGAC   1380   - - TGATCGCGCT GGCGATCCGC AAGGCGCGGC CCGACCTTCG CGTGCTGCTG CT -#GGACCGTG   1440   - - CGGCGGGCGC CTCGGACGGG CATACTTGGT CCTGCCACGA CACCGATTTG GC -#GCCGCACT   1500   - - GGCTGGACCG CCTGAAGCCG ATCAGGCGTG GCGACTGGCC CGATCAGGAG GT -#GCGGTTCC   1560   - - CAGACCATTC GCGAAGGCTC CGGGCCGGAT ATGGCTCGAT CGACGGGCGG GG -#GCTGATGC   1620   - - GTGCGGTGAC C               - #                  - #  - #     1631__________________________________________________________________________
Patent CitationsCited PatentFiling datePublication dateApplicantTitleEP0393690A1 *Apr 20, 1990Oct 24, 1990Kirin Beer Kabushiki KaishaDNA sequences useful for the synthesis of carotenoidsEP0725137A1 *Aug 18, 1995Aug 7, 1996Kirin Beer Kabushiki KaishaKeto group introducing enzyme, dna coding for the same, and process for producing ketocarotenoid* Cited by examinerNon-Patent CitationsReference1Johnson, E., et al., "Astaxanthin from Microbal Sources," Critical Reviews in Biotechnology, vol. 11, No. 4, pp. 297-326 (1991).2 *Johnson, E., et al., Astaxanthin from Microbal Sources, Critical Reviews in Biotechnology, vol. 11, No. 4, pp. 297 326 (1991).3Misawa, N., et al., "Elucidation of the Erwinia uredovora Carotenoid Biosynthetic Pathway by Functional Analysis of Gene Products Expressed in Escherichia coli," Journal of Bacteriology, vol. 172, No. 12, pp. 6704-6712 (Dec. 1990).4 *Misawa, N., et al., Elucidation of the Erwinia uredovora Carotenoid Biosynthetic Pathway by Functional Analysis of Gene Products Expressed in Escherichia coli , Journal of Bacteriology, vol. 172, No. 12, pp. 6704 6712 (Dec. 1990).5N. Misawa et al., "Elucidation of an Astaxanthin Biosynthetic Pathway at the Level of the Biosynthesis Genes", Chemical Abstracts, vol. 123, No. 11, Sep. 1995.6 *N. Misawa et al., Elucidation of an Astaxanthin Biosynthetic Pathway at the Level of the Biosynthesis Genes , Chemical Abstracts, vol. 123, No. 11, Sep. 1995.7Yokoyama, A., et al., "Production of Astaxanthin and 4-Ketozeaxanthin by the Marine Bacterium, Agrobacterium aurantiacum," Bioschi. Biotech. Biochem., vol. 58, No. 10, pp. 1842-1844 (Oct. 1, 1994).8 *Yokoyama, A., et al., Production of Astaxanthin and 4 Ketozeaxanthin by the Marine Bacterium, Agrobacterium aurantiacum , Bioschi. Biotech. Biochem., vol. 58, No. 10, pp. 1842 1844 (Oct. 1, 1994).* Cited by examinerReferenced byCiting PatentFiling datePublication dateApplicantTitleUS6784351Jun 26, 2002Aug 31, 2004Ball Horticultural CompanyTargetes erecta marigolds with altered carotenoid compositions and ratiosUS7033622Dec 19, 2002Apr 25, 2006Ball Horticultural CompanyRegenerable portion thereof, a hybrid or later generation whose petals, leaves or both contain an enhanced ratio of one or more carotenoid compounds relative to luteinUS7081478Jun 3, 2003Jul 25, 2006Chrysantis, Inc.Mixed zeaxanthin ester concentrate and uses thereofUS7223909Mar 20, 2003May 29, 2007Ball HorticulturalGenome contains a transgene that encodes a chimeric ketolase enzyme polypeptide having two portions, an N-terminal portion containing plastid transit peptide portion fused to a second ketolase enzyme portionUS7252985Dec 17, 2004Aug 7, 2007E. I. Du Pont De Nemours And CompanyCarotenoid ketolasesUS7393671Mar 30, 2006Jul 1, 2008E.I. Du Pont De Nemours And CompanyMutant carotenoid ketolasesUS7422873Mar 31, 2006Sep 9, 2008E.I. Du Pont De Nemours And CompanyMutant carotenoid ketolaseUS7575766May 29, 2003Aug 18, 2009Ball Horticultural CompanyTagetes erecta with altered carotenoid compositions and ratiosUS7851199Mar 20, 2006Dec 14, 2010Microbia, Inc.Production of carotenoids in oleaginous yeast and fungiUS8288149Oct 13, 2010Oct 16, 2012Dsm Ip Assets B.V.Production of carotenoids in oleaginous yeast and fungiUS8691555Sep 28, 2007Apr 8, 2014Dsm Ip Assests B.V.Production of carotenoids in oleaginous yeast and fungiWO2007087815A2Dec 19, 2005Jun 17, 2006Metanomics GmbhProcess for the control of production of fine chemicalsClassifications U.S. Classification435/67, 536/23.2, 435/148, 435/252.33, 536/23.7, 435/252.3, 435/189, 435/320.1International ClassificationC12P23/00, C12N15/53, C12N9/02Cooperative ClassificationC12N9/0093, C12P23/00, C12N9/0004European ClassificationC12N9/00P36, C12P23/00, C12N9/00PLegal EventsDateCodeEventDescriptionApr 25, 2012FPAYFee paymentYear of fee payment: 12Jun 26, 2008ASAssignmentOwner name: KIRIN HOLDINGS KABUSHIKI KAISHA, JAPANFree format text: CHANGE OF NAME;ASSIGNOR:KIRIN BEER KABUSHIKI KAISHA;REEL/FRAME:021147/0855Effective date: 20071120Owner name: KIRIN HOLDINGS KABUSHIKI KAISHA,JAPANFree format text: CHANGE OF NAME;ASSIGNOR:KIRIN BEER KABUSHIKI KAISHA;REEL/FRAME:21147/855May 19, 2008FPAYFee paymentYear of fee payment: 8May 16, 2008ASAssignmentOwner name: KIRIN HOLDINGS KABUSHIKI KAISHA, JAPANFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MARINE BIOTECHNOLOGY INSTITUTE CO., LTD.;REEL/FRAME:020951/0415Effective date: 20080319May 4, 2004FPAYFee paymentYear of fee payment: 4RotateOriginal ImageGoogle Home - Sitemap - USPTO Bulk Downloads - Privacy Policy - Terms of Service - About Google Patents - Send FeedbackData provided by IFI CLAIMS Patent Services©2012 Google